Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10.12% saline----1件: 299
20.9% Isotonic Saline (IS)----1件: 299
30.9% Isotonic Saline (IS), 4mL----1件: 299
40.9% normal saline (control)----1件: 299
50.9% w/v sodium chloride solution2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
6033841----1件: 299
71,5 (Butylimino)-1,5-dideoxy-D-glucitol1件: Sorbitol1件: D00096 --1件: 299
81-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline carboxylic acid----1件: 299
9100 mg ELX (VX-445) / 50 mg TEZ / 75 mg IVA FDC----1件: 299
10100 mg ELX /50 mg TEZ /75 mg IVA FDC----1件: 299
11100 mg ELX/50 mg TEZ /75 mg IVA FDC----1件: 299
12100 mg ELX/50 mg TEZ/75 mg IVA fixed dose combination----1件: 299
13100 mg TEZ/150 mg IVA FDC----1件: 299
14100 mg VX-445 /50 mg TEZ/75 mg IVA FDC----1件: 299
15100 mg VX-445/50 mg TEZ /75 mg IVA FDC----1件: 299
16100 mg/m2 dose----1件: 299
17100-mg ELX (VX-445) / 50-mg TEZ / 75-mg IVA FDC----1件: 299
18100-mg ELX (VX-455) / 50-mg TEZ / 75-mg IVA FDC----1件: 299
19100-mg ELX / 50-mg TEZ / 75 -mg----1件: 299
20100-mg ELX / 50-mg TEZ / 75 -mg IVA FDC----1件: 299
21100-mg VX-445 / 50-mg TEZ / 75- mg IVA FDC----1件: 299
22100-mg VX-445 / 50-mg TEZ / 75-mg IVA FDC----1件: 299
23100-mg VX-445 /50-mg TEZ/75-mg----1件: 299
24100-mg VX-445/50-mg TEZ/75-mg IVA FDC----1件: 299
25100g ELX / 50mg TEZ / 75mg IVA----1件: 299
26100mg ELX/50mg TEZ /75mg IVA----1件: 299
27100mg VX-445/50mg TEZ /75mg IVA FDC----1件: 299
28129Xe Small and Large Human Lung Coil----1件: 299
2913^C Spirulina Platensis Gastric Emptying Breath Test (GEBT)1件: Spirulina platensis---1件: 299
30150-mg IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
31150mg IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
322% Chlorhexidine solution wipes1件: Chlorhexidine4件: D00858 ,
D01345 ,
D03463 ,
D07668 		--1件: 299
332,3-dihydroxybutanedioic acid----1件: 299
342-aminoethanethiol1件: Cysteamine2件: D03634 ,
D03635 		--2件: 19, 299
35200 mg/m2 dose----1件: 299
3625-Hydroxyvitamin D31件: Calcifediol1件: D00122 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
372622U90 Duramycin1件: Lancovutide---1件: 299
38291844----2件: 246, 299
393He Human Lung Coil----1件: 299
404% chlorhexidine gluconate liquid skin cleanser1件: Chlorhexidine4件: D00858 ,
D01345 ,
D03463 ,
D07668 		--1件: 299
414-phenylbutyrate1件: Phenylbutyric acid---2件: 251, 299
424.2% NaCl/Inhalation solution----1件: 299
434D-710----1件: 299
445-methyltetrahydrofolate and vitamin B121件: Cyanocobalamin4件: D00166 ,
D03615 ,
D03616 ,
D03617 		--1件: 299
4550 mg ELX/25 mg TEZ/37.5 mg IVA----1件: 299
4650 mg ELX/25 mg TEZ/37.5 mg IVA fixed dose combination----1件: 299
475000 IU of cholecalciferol1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
48552-02----2件: 53, 299
496% Hypertonic Saline (HS), 4mL----1件: 299
507% Hypertonic Saline (HS)----1件: 299
517% NaCl----1件: 299
527% saline----1件: 299
5375-mg IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
5480mg ELX / 40mg TEZ / 60mg IVA----1件: 299
55A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP)----1件: 299
56AAC Hexal----1件: 299
57ABBV-119----1件: 299
58ABBV-2222----1件: 299
59ABBV-3067----1件: 299
60ABELCET1件: Amphotericin B1件: D00203 --1件: 299
61ACC----1件: 299
62ACC600Tabs----1件: 299
63Acebilustat1件: Acebilustat---1件: 299
64Acetate1件: Acetate---43件: 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299
65Acetylcysteine1件: Acetylcysteine1件: D00221 --20件: 6, 13, 19, 20, 34, 49, 51, 53, 58, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337
66ACETYLCYSTEINE SODIUM1件: Acetylcysteine1件: D00221 --1件: 299
67ACIDE TRANEXAMIQUE MYLAN 0,5 g/ 5 mL, solution injectable----1件: 299
68Activated smart device----1件: 299
69Active Treatment Group 7% Hypertonic Saline----1件: 299
70Actrapid 100 IU/ml, Solution for injection in a vial----1件: 299
71Actrapid Penfill 100UI/ml----1件: 299
72Acute Antioxidant----1件: 299
73Ad26.COV2-S.02----1件: 299
74Adempas1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬5件: 51, 86, 88, 225, 299
75Adempas 0.125 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 299
76Adempas 0.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
77Adempas 1.0 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
78Adempas 2.0 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
79Adeno-associated virus-CFTR vector----1件: 299
80Adrenalina----1件: 299
81Advagraf prolonged-release hard capsules2件: Manganese citrate,
Tacrolimus		2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
82AER002----1件: 299
83Aeroquin----1件: 299
84Aerosolized, human, plasma-derived Alpha-1 Antitrypsin----1件: 299
85Aerosoltherapy----1件: 299
86AeroVanc----1件: 299
87Air----8件: 3, 13, 51, 58, 85, 97, 193, 299
88AIR DNase----1件: 299
89AIR DNase™----1件: 299
90Airway clearance technique----1件: 299
91Ajulemic acid1件: Ajulemic acid1件: D11312 1件: CNR2 💬1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299
92Alanine1件: Alanine1件: D00012 --5件: 6, 13, 251, 298, 299
93Albuterol1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 12, 13, 86, 89, 113, 231, 256, 299
94Albuterol inhaler.1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 231, 299
95Alendronate1件: Alendronic acid2件: D00939 ,
D07119 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬7件: 19, 41, 46, 50, 271, 274, 299
96Alendronate sodium1件: Alendronic acid2件: D00939 ,
D07119 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 19, 299
97Alginate1件: Alginic acid1件: D02324 --2件: 53, 299
98Alginate oligosaccharide1件: Alginic acid1件: D02324 --1件: 299
99Allo-hMSCs----2件: 211, 299
100Alpha-1 HC 100 mg----1件: 299
101Alpha-1 HC 200 mg----1件: 299
102Alpha1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---2件: 231, 299
103Alpha1-Proteinase Inhibitor (Human)1件: Alpha-1-proteinase inhibitor---2件: 231, 299
104ALTU-1351件: ALTU-135---1件: 299
105ALTUS-135----1件: 299
106ALX-009----1件: 299
107AMIKACIN1件: Amikacin2件: D00865 ,
D02543 		--2件: 60, 299
108Amikacin nebulization1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
109AMIKACIN SULFATE2件: Amikacin,
Sulfate ion		2件: D00865 ,
D02543 		--1件: 299
110Amikacina1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
111Amikacina liposomal (Arikace?)1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
112Amikacine1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
113Amikacine nebulization1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
114Amikin, amiklin, amicacin, BB-K8, Biklin, Fabianol, Kaminax, Mikavir, Novamin, Pierami1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
115Amikin®, amiklin, amicacin, BB-K8, Biklin®, Fabianol®, Kaminax, Mikavir, Novamin®, Pierami1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
116AMILASA----1件: 299
117Amiloride1件: Amiloride2件: D00649 ,
D07447 		3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬4件: 13, 67, 225, 299
118Amiloride HCl1件: Amiloride2件: D00649 ,
D07447 		3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 299
119Amiloride Solution for Inhalation1件: Amiloride2件: D00649 ,
D07447 		3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 299
120Amitriptylin1件: Amitriptyline2件: D00809 ,
D07448 		2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
121Amitriptylin-CT1件: Amitriptyline2件: D00809 ,
D07448 		2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
122Amitriptylin-ct Tabletten1件: Amitriptyline2件: D00809 ,
D07448 		2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
123Amitriptyline1件: Amitriptyline2件: D00809 ,
D07448 		2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 78, 97, 226, 299
124Amoxicillin1件: Amoxicillin3件: D00229 ,
D02925 ,
D07452 		--7件: 6, 46, 63, 96, 97, 222, 299
125Amoxicillin and Clavulanic acid1件: Clavulanic acid1件: D07711 --1件: 299
126Amphotericin----1件: 299
127Amphotericin B1件: Amphotericin B1件: D00203 --1件: 299
128AMYLASE----1件: 299
129Anakinra1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬17件: 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299
130Andecaliximab----4件: 46, 96, 97, 299
131Anti-pseudomonas IgY gargle----1件: 299
132Anti-reflux pharmacotherapy----1件: 299
133Antibiotic----1件: 299
134Antioxidant Cocktail----1件: 299
135Antistaminici H1 - H2----1件: 299
136AP----4件: 2, 6, 13, 299
137AP-PA02----1件: 299
138API----2件: 231, 299
139AquADEK----1件: 299
140AquADEKs-2----1件: 299
141ARD-3150----1件: 299
142Arginine1件: Arginine1件: D02982 --11件: 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299
143Aridol1件: Mannitol1件: D00062 --1件: 299
144Aridol or Osmohale1件: Mannitol1件: D00062 --1件: 299
145ARIKACE™----1件: 299
146Arikayce1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
147Arikayce™1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
148Arikayce™ 140 mg1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
149Arikayce™ 560 mg1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
150Arikayce™ 70 mg1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
151ARO-ENaC----1件: 299
152ATALUREN1件: Ataluren1件: D09323 --6件: 19, 113, 140, 246, 299, 329
153Ataluren (PTC124®)1件: Ataluren1件: D09323 --1件: 299
154Atorvastatin1件: Atorvastatin3件: D00258 ,
D00887 ,
D07474 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬18件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299
155Atropina1件: Atropine5件: D00113 ,
D01077 ,
D02069 ,
D03011 ,
D03814 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299
156Augmentin1件: Clavulanic acid1件: D07711 --1件: 299
157Aurexis----1件: 299
158Aurexis® (tefibazumab)1件: Tefibazumab1件: D06054 --1件: 299
159Avian polyclonal IgY antibody against PA----1件: 299
160Avibactam1件: Avibactam---1件: 299
161AZD1236----1件: 299
162AZD5634----1件: 299
163AZD5634 for infusion----1件: 299
164AZD5634 for inhalation----1件: 299
165AZD7986----2件: 44, 299
166AZD9668----1件: 299
167Azithromycin1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--6件: 13, 84, 85, 96, 228, 299
168Azithromycin 250 mg tablets1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 299
169Azithromycin 500 mg film-coated tablet1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 299
170AZITHROMYCIN DIHYDRATE1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--2件: 228, 299
171AZLI----1件: 299
172AZLI 75 mg three times a day (TID)----1件: 299
173AZLI 75 mg three times daily (TID)----1件: 299
174AZLI 75 mg two times a day (BID)/ three times a day (TID)----1件: 299
175AZLI 75 mg two times a day (BID)/three times a day (TID)----1件: 299
176Aztreonam1件: Aztreonam2件: D00240 ,
D06558 		--2件: 228, 299
177Aztreonam for Inhalation (AI)1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
178Aztreonam for Inhalation Solution1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
179Aztreonam for Inhalation Solution (AZLI)1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
180AZTREONAM LYSINE2件: Aztreonam,
Lysine		3件: D00240 ,
D02304 ,
D06558 		--1件: 299
181Aztreonam Lysine for Inhalation2件: Aztreonam,
Lysine		3件: D00240 ,
D02304 ,
D06558 		--1件: 299
182Aztreonam solución para inhalación1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
183Aztreonan lysine1件: Lysine1件: D02304 --1件: 299
184Bactrim1件: Trimethoprim2件: D00145 ,
D06236 		--1件: 299
185BAL----5件: 49, 51, 84, 85, 299
186Balance1件: Isoxaflutole---8件: 6, 11, 13, 81, 113, 122, 149, 299
187BAY 85-8501----1件: 299
188BAY q 3939----1件: 299
189BAY63-2521----3件: 51, 86, 299
190BAY85-8501----1件: 299
191BAYQ3939----1件: 299
192BCG----1件: 299
193BCG TICE Vaccine----1件: 299
194Behavioral: Aerobic exercise----1件: 299
195Behavioral: Balance exercise1件: Isoxaflutole---1件: 299
196Behavioral: Environmental Decontamination----1件: 299
197Behavioral: Exercise----3件: 6, 265, 299
198Behavioral: Flexibility and postural exercise----1件: 299
199Behavioral: Resistance exercise----1件: 299
200Behavioral: Tobacco Treatment Specialist (TTS) intervention1件: Tobacco leaf---1件: 299
201Behavioral: Unsupervised exercise----1件: 299
202Benralizumab1件: Benralizumab1件: D09874 1件: IL5RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299
203Beta-Adrenergic cocktail----1件: 299
204Bethkis----1件: 299
205BH4----5件: 51, 86, 124, 240, 299
206BH4 20mg----1件: 299
207BH4 5mg----1件: 299
208BI 1265162----1件: 299
209BI 1265162 10 µg----1件: 299
210BI 1265162 100 µg----1件: 299
211BI 1265162 25 µg----1件: 299
212BI 1265162 50 µg----1件: 299
213BI 1323495----1件: 299
214BI 443651----1件: 299
215Biaxin ( clarithromycin)1件: Clarithromycin1件: D00276 --1件: 299
216BIIL 283 BS (Amelubent)----1件: 299
217BIIL 284 BS, high dose----1件: 299
218BIIL 284 BS, high dose, adult patients----1件: 299
219BIIL 284 BS, high dose, pediatric patients----1件: 299
220BIIL 284 BS, low dose----1件: 299
221BIIL 284 BS, low dose, adult patients----1件: 299
222BIIL 284 BS, low dose, pediatric patients----1件: 299
223BIIL 284 BS, medium dose, adult patients----1件: 299
224BIIL 284 BS, medium dose, pediatric patients----1件: 299
225Biklin----1件: 299
226Bio-25 probiotic----1件: 299
227Bisphosphonate treatment----2件: 113, 299
228BLF----1件: 299
229Blood draw----5件: 6, 19, 65, 231, 299
230Blood draw.----2件: 231, 299
231Blood sample----18件: 8, 13, 46, 49, 51, 53, 61, 65, 66, 84, 96, 97, 107, 127, 235, 274, 288, 299
232Blood sampling for determination of serum Zn----1件: 299
233Blood test----6件: 36, 51, 86, 113, 162, 299
234Boost VHC----1件: 299
235Boots High Strength Garlic Odour Controlled1件: Garlic1件: D12020 --1件: 299
236BRAMICIL - 100 MG/ 2 ML SOLUZIONE INIETTABILE 10 FIALE DA 2 ML----1件: 299
237Bramitob----1件: 299
238BRAMITOB - 300 MG/4 ML SOLUZIONE DA NEBULIZZARE 56 CONTENITORI MONODOSE 4 ML----1件: 299
239Bramitob 300mg/4ml Nebuliser Solution----1件: 299
240BRAMITOB*NEBUL 28F 300MG/4ML----1件: 299
241BRAMITOB*NEBUL 56F 300MG/4ML----1件: 299
242Bramitob® administered by PARI eFlow® rapid electronic nebulizer----1件: 299
243Bramitob® administered by PARI LC® PLUS nebulizer----1件: 299
244Brensocatib1件: Brensocatib1件: D12120 1件: CTSC 💬2件: Apoptosis, Lysosome 💬1件: 299
245Brensocatib 10 mg1件: Brensocatib1件: D12120 1件: CTSC 💬2件: Apoptosis, Lysosome 💬1件: 299
246Brensocatib 25 mg1件: Brensocatib1件: D12120 1件: CTSC 💬2件: Apoptosis, Lysosome 💬1件: 299
247Broccoli1件: Broccoli---3件: 36, 97, 299
248Broccoli sprouts1件: Broccoli---1件: 299
249Bronchial mucus collection----1件: 299
250Bronchitol1件: Mannitol1件: D00062 --1件: 299
251Bronchoscopy with BAL----1件: 299
252Bucelipase alfa1件: Bucelipase alfa---1件: 299
253BUDESONIDE1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬9件: 66, 93, 94, 95, 96, 97, 98, 228, 299
254Budesonide-formoterol single inhaler2件: Budesonide,
Formoterol		4件: D00246 ,
D01373 ,
D05277 ,
D07990 		2件: ADRB2,
NR3C1 💬		9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
255Burlulipase1件: Burlulipase---1件: 299
256BX004-A----1件: 299
257C01CA04 - Dopamina1件: Dopamine2件: D00633 ,
D07870 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 299
258Calcium1件: Calcium---30件: 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299
259Calcium carbonate3件: Calcium,
Calcium carbonate,
Carbonate ion		2件: D00932 ,
D10802 		--8件: 13, 19, 46, 53, 75, 96, 235, 299
260Calfactant1件: Calfactant1件: D03317 --1件: 299
261Carbonate1件: Carbonate ion---12件: 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299
262Cavosonstat1件: Cavosonstat1件: D10916 --1件: 299
263Cayston1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
264Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
265CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
266CB-280----1件: 299
267CEFALEXIN1件: Cephalexin2件: D00263 ,
D00906 		--1件: 299
268Cefepime1件: Cefepime1件: D02376 --2件: 60, 299
269Ceftaroline1件: Ceftaroline fosamil1件: D08884 --1件: 299
270Ceftazidim1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
271Ceftazidim Fresenius Kabi1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
272Ceftazidim Fresenius Kabi 2000 mg poeder voor oplossing voor injectie of infusie1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
273Ceftazidima1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
274CEFTAZIDIMA PENTAIDRATO1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
275CEFTAZIDIME1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
276Ceftazidime and tobramycin2件: Ceftazidime,
Tobramycin		4件: D00063 ,
D00921 ,
D02542 ,
D07654 		--1件: 299
277CEFTAZIDIME PENTAHYDRATE1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
278Ceftazidime/avibactam2件: Avibactam,
Ceftazidime		2件: D00921 ,
D07654 		--1件: 299
279Ceftolozane1件: Ceftolozane1件: D10097 --1件: 299
280Ceftolozane/Tazobactam2件: Ceftolozane,
Tazobactam		2件: D00660 ,
D10097 		--1件: 299
281Cefuroxim1件: Cefuroxime4件: D00262 ,
D00914 ,
D00915 ,
D03431 		--1件: 299
282Cefuroxime1件: Cefuroxime4件: D00262 ,
D00914 ,
D00915 ,
D03431 		--2件: 97, 299
283Cephalexin1件: Cephalexin2件: D00263 ,
D00906 		--1件: 299
284CF patients with a G551D mutation and treated with Ivacaftor1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
285CFTR Modulators----1件: 299
286CFTR potentiator----1件: 299
287ChAdOx1 nCoV-191件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 299
288CHF 6333----1件: 299
289CHF6333 (Part 1 - SAD)----1件: 299
290CHF6333 (Part 2 - MAD)----1件: 299
291Chlorhexidine1件: Chlorhexidine4件: D00858 ,
D01345 ,
D03463 ,
D07668 		--2件: 86, 299
292Chlorhexidine Gluconate1件: Chlorhexidine4件: D00858 ,
D01345 ,
D03463 ,
D07668 		--1件: 299
293Chlorhexidine gluconate oral rinse1件: Chlorhexidine4件: D00858 ,
D01345 ,
D03463 ,
D07668 		--1件: 299
294Chloride1件: Chloride ion---29件: 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 271, 288, 296, 297, 299, 338
295CHOLECALCIFEROL1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬10件: 13, 19, 34, 46, 49, 75, 96, 97, 298, 299
296Cholecalciferol (Vitamin D3)1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 13, 299
297Cholecalciferol (vitaminD3)1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
298Cholecalciferol Pill1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
299Choline1件: Choline1件: D07690 --4件: 93, 171, 193, 299
300Choline Chloride2件: Chloride ion,
Choline		1件: D07690 --1件: 299
301Choline supplementation1件: Choline1件: D07690 --1件: 299
302Chronic Antioxidant----1件: 299
303Cipro (Ciprofloxacin, BAYQ3939)1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
304Cipro Inhale1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
305Ciprofloxacin1件: Ciprofloxacin2件: D00186 ,
D02216 		--5件: 2, 60, 96, 97, 299
306Ciprofloxacin (BAYQ3939) dry powder for inhalation1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
307Ciprofloxacin (Cipro Inhale, BAYQ3939)1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
308Ciprofloxacin (Cipro, BAYQ3939)1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
309Ciprofloxacin (ciproxin)1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
310Ciprofloxacin dispersion for inhalation1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
311Ciprofloxacin DPI1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
312Ciprofloxacin DPI (BAYQ3939)1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
313Ciprofloxacin for Inhalation1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
314Ciprofloxacin hydrochloride1件: Ciprofloxacin2件: D00186 ,
D02216 		--2件: 96, 299
315CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
316Ciprofloxacin Inhale1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
317Ciprofloxacina----1件: 299
318CIPROFLOXACINA CLORIDRATO----1件: 299
319Ciproxin----1件: 299
320CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE----1件: 299
321Ciproxin Suspension----1件: 299
322CIPROXIN*6CPR RIV 500MG----1件: 299
323Clarithromycin1件: Clarithromycin1件: D00276 --8件: 6, 63, 84, 96, 97, 222, 228, 299
324Claritromycin----1件: 299
325Claritromycin 500mg film coated tablets----1件: 299
326Clavulanate1件: Clavulanic acid1件: D07711 --1件: 299
327CLAVULANIC ACID1件: Clavulanic acid1件: D07711 --1件: 299
328Clindamycin1件: Clindamycin4件: D00277 ,
D01073 ,
D01990 ,
D02132 		--2件: 46, 299
329CLORURO SODICO 7%----1件: 299
330Cobamamide1件: Cobamamide1件: D00042 --1件: 299
331Colimicina----1件: 299
332COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 4 ML----1件: 299
333Colimycine----1件: 299
334COLIMYCINE inhalation----1件: 299
335COLIMYCINE injectable----1件: 299
336COLISTIMETATO SODICO----1件: 299
337Colistimethat-Natrium----1件: 299
338COLISTIMETHATE1件: Colistimethate1件: D02049 --1件: 299
339Colistimethate 75 mg inhaled two times daily1件: Colistimethate1件: D02049 --1件: 299
340COLISTIMETHATE SODIUM1件: Colistimethate1件: D02049 --1件: 299
341COLISTIMETHATE SODIUM (A COMPONENT)1件: Colistimethate1件: D02049 --1件: 299
342Colistimethate sodium (BAN, USAN), Colistimethatum natricum, Colistin sodium methanesulfonate2件: Colistimethate,
Colistin		3件: D02049 ,
D02138 ,
D07746 		--1件: 299
343Colistimethate sodium (promixin)1件: Colistimethate1件: D02049 --1件: 299
344COLISTIN1件: Colistin2件: D02138 ,
D07746 		--1件: 299
345Colistin CF1件: Colistin2件: D02138 ,
D07746 		--1件: 299
346Colistin Forest - Trockenstechampullen mit Lösungsmittel1件: Colistin2件: D02138 ,
D07746 		--1件: 299
347COLISTIN MESILATE SODIUM1件: Colistin2件: D02138 ,
D07746 		--1件: 299
348Colistineb----1件: 299
349COLISTINEB 2MUI----1件: 299
350Colobreathe1件: Colistimethate1件: D02049 --1件: 299
351Colomycin----1件: 299
352Comirnaty1件: Pfizer-BioNTech COVID-19 Vaccine1件: D11971 --5件: 13, 46, 51, 53, 299
353Comirnaty concentrate for dispersion for injection1件: Pfizer-BioNTech COVID-19 Vaccine1件: D11971 --2件: 53, 299
354Compound 1a----2件: 246, 299
355Continuous glucose monitor (CGM)2件: Dextrose, unspecified form,
Methamidophos		---1件: 299
356Continuous glucose monitoring1件: Dextrose, unspecified form---2件: 75, 299
357Continuous Glucose Monitoring System (CGMS)1件: Dextrose, unspecified form---1件: 299
358Continuous infusion Cefepime1件: Cefepime1件: D02376 --1件: 299
359Continuous infusion Ceftazidime1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
360Continuous infusion Meropenem1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
361Continuous infusion Piperacillin tazobactam2件: Piperacillin,
Tazobactam		4件: D00466 ,
D00660 ,
D02251 ,
D08380 		--1件: 299
362Continuous infusion Ticarcillin-clavulanate2件: Clavulanic acid,
Ticarcillin		2件: D07711 ,
D08593 		--1件: 299
363Control----4件: 6, 46, 168, 299
364Control Group 0.9% Isotonic Saline----1件: 299
365Control multivitamin----1件: 299
366COVID-19 mRNA vaccine (nucleoside-modified)----4件: 13, 46, 51, 299
367COVID-19 mRNA vaccine Moderna (CX-024414)----4件: 13, 46, 51, 299
368COVID-19 vaccine (Ad26.COV2-S [recombinant])----1件: 299
369COVID-19 Vaccine (ChAdOx1-S [recombinant])----3件: 46, 51, 299
370COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19)1件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 299
371Covid-19 Vaccine Janssen1件: Janssen COVID-19 Vaccine1件: D12129 --2件: 53, 299
372COVID-19 Vaccine Janssen suspension for injection1件: Janssen COVID-19 Vaccine1件: D12129 --1件: 299
373COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant])1件: Janssen COVID-19 Vaccine1件: D12129 --2件: 53, 299
374COVID-19 Vaccine Moderna1件: Moderna COVID-19 Vaccine1件: D12114 --4件: 46, 51, 65, 299
375COVID-19 Vaccine Moderna dispersion for injection1件: Moderna COVID-19 Vaccine1件: D12114 --1件: 299
376CPX----2件: 215, 299
377CR0021件: CR002---1件: 299
378CR002 Liquid API1件: CR002---1件: 299
379CRC3357, ZK-355322, Leukoton----1件: 299
380CREON----2件: 298, 299
381Creon 10.000, hårde enterokapsler----1件: 299
382Creon 10000----2件: 298, 299
383CREON 10000 Capsules----1件: 299
384Creon 25.000, hårde enterokapsler----1件: 299
385Creon 25000----2件: 298, 299
386Creon 40.000, hårde enterokapsler----1件: 299
387CREON IR----1件: 299
388Creon N----1件: 299
389CREON N 25000----1件: 299
390Creon®----1件: 299
391Creon® (DR/GR)----1件: 299
392Creon® 25,000----1件: 299
393Crestor1件: Rosuvastatin2件: D01915 ,
D08492 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 49, 79, 299
394CSL787----1件: 299
395CTX-4430----1件: 299
396Curcuma Longa1件: Turmeric---2件: 96, 299
397Curcuma Longa Extract1件: Turmeric---1件: 299
398Curcuma Longa Extract cpl formaat 00 23,2 x 8,5 mm 723 mg1件: Turmeric---1件: 299
399Curcumin1件: Curcumin---11件: 2, 13, 46, 49, 67, 74, 94, 96, 97, 139, 299
400CYC202----1件: 299
401CYCLO[L-ALANYL-L-SERYL-L-ISOLEUCYL-L-PROLYL-L-PROLYL-L-GLUTAMINYL-L-LYSYL-L-TYROSYL-D-PROLYL-L-PROLYL-(2S)-2-AMINODECANOYL-L-ALPHA-GLUTAMYL-L-THREONYL]----1件: 299
402CYSTAGON1件: Cysteamine2件: D03634 ,
D03635 		--3件: 8, 19, 299
403Cystagon (cysteamine bitartrate) immediate-release capsules1件: Cysteamine2件: D03634 ,
D03635 		--1件: 299
404Cysteamine1件: Cysteamine2件: D03634 ,
D03635 		--4件: 8, 19, 21, 299
405Cysteamine Bitartrate1件: Cysteamine2件: D03634 ,
D03635 		--4件: 8, 19, 21, 299
406Cysteamine bitartrate (Cystagon)1件: Cysteamine2件: D03634 ,
D03635 		--1件: 299
407Cystic Fibrosis Ready to Use Supplemental Food----1件: 299
408D-a-tocopheryl PEG 1000 succinate----1件: 299
409D-glucitol1件: Sorbitol1件: D00096 --2件: 28, 299
410D-IVA----1件: 299
411D6-25-hydroxyvitamin D31件: Calcifediol1件: D00122 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
412DCI----2件: 6, 299
413DCI 1020----1件: 299
414De-activated smart device----1件: 299
415Decolonization----1件: 299
416Denosumab1件: Denosumab1件: D03684 1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬7件: 46, 50, 93, 95, 96, 274, 299
417Denufosol1件: Denufosol---1件: 299
418Denufosol tetrasodium (INS37217)1件: Denufosol---1件: 299
419Denufosol Tetrasodium (INS37217) Inhalation Solution1件: Denufosol---1件: 299
420Denufosol tetrasodium Inhalation Solution1件: Denufosol---1件: 299
421DEPELESTAT----1件: 299
422Desoxyribonuclease1件: Desoxyribonuclease---1件: 299
423Detemir1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
424Detoxifying agents for antineoplastic treatment----2件: 299, 337
425Deuterated Ivacaftor1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
426DEUTIVACAFTOR1件: Deutivacaftor1件: D11423 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
427Dexamethasone1件: Dexamethasone9件: D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
428Dexamethasone sodium phosphate 250 mg/10 ml solution2件: Dexamethasone,
Phosphate ion		9件: D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 299
429DHA----8件: 6, 46, 48, 49, 94, 113, 299, 301
430Diagnostic Test: Candy Glucose Tolerance Test1件: Dextrose, unspecified form---1件: 299
431Diagnostic Test: Continuous glucose monitoring1件: Dextrose, unspecified form---1件: 299
432Diagnostic Test: Dexa scan----1件: 299
433Diagnostic Test: Infant PFT----1件: 299
434Diagnostic Test: Injected abdominal CT----1件: 299
435Diagnostic Test: Iontophoresis sessions in forearm of subjects with pilocarpine1件: Pilocarpine3件: D00525 ,
D02200 ,
D05478 		2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299
436Diagnostic Test: Lung Clearance Index----1件: 299
437Diagnostic Test: Measurement of Sweat Chloride and Sweat Bromide1件: Chloride ion---1件: 299
438Diagnostic Test: Nasal brushing----1件: 299
439Diagnostic Test: Oral glucose tolerance test1件: Dextrose, unspecified form---3件: 13, 65, 299
440Diagnostic Test: Passive tidal breathing----1件: 299
441Diagnostic Test: Xenon1件: Xenon2件: D01901 ,
D06339 		--1件: 299
442DICLOXACILLIN1件: Dicloxacillin2件: D02137 ,
D02348 		--1件: 299
443Diet----3件: 97, 240, 299
444Digitoxin1件: Digitoxin1件: D00297 4件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4 💬		18件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
445Docosahexaenoic acid1件: Doconexent---7件: 6, 49, 90, 94, 240, 299, 301
446Docosahexaenoic Acid (DHA)1件: Doconexent---3件: 6, 94, 299
447Docosahexaenoic acid administration: 50 mg/kg/day during 12 months1件: Doconexent---1件: 299
448Docosahexanoic Acid Supplement----1件: 299
449Dopamina1件: Dopamine2件: D00633 ,
D07870 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 299
450DORIBAX1件: Doripenem1件: D03895 --1件: 299
451Doripenem1件: Doripenem1件: D03895 --1件: 299
452DORIPENEM HYDRATE1件: Doripenem1件: D03895 --1件: 299
453Dornase alfa1件: Dornase alfa1件: D03896 --2件: 53, 299
454Dornase alfa (Pulmozyme)1件: Dornase alfa1件: D03896 --1件: 299
455Dornase alfa [Pulmozyme®]1件: Dornase alfa1件: D03896 --1件: 299
456Dornase alpha1件: Dornase alfa1件: D03896 --1件: 299
457Doxycyclin1件: Doxycycline5件: D00307 ,
D02129 ,
D03903 ,
D03904 ,
D07876 		--2件: 97, 299
458Doxycycline1件: Doxycycline5件: D00307 ,
D02129 ,
D03903 ,
D03904 ,
D07876 		--16件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299
459DP Mannitol1件: Mannitol1件: D00062 --1件: 299
460Dry powder tobramycin1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
461DTPA1件: Pentetic acid1件: D05422 --2件: 28, 299
462Dual Energy X-ray Absorptiometry (DEXA)----1件: 299
463Dulaglutide1件: Dulaglutide1件: D09889 1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 299
464Dulaglutide 0.75Mg/0.5Ml Inj Pen1件: Dulaglutide1件: D09889 1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 299
465DURAMYCIN1件: Lancovutide---1件: 299
466Duramycin, 2622U901件: Lancovutide---1件: 299
467DX-890----1件: 299
468Ebselen1件: Ebselen---1件: 299
469ECGC----1件: 299
470EGCG1件: Epigallocatechin gallate---9件: 6, 8, 13, 17, 28, 85, 113, 206, 299
471EGCG + Tocotrienol2件: Epigallocatechin gallate,
Tocotrienol		---1件: 299
472Elasomeran1件: Moderna COVID-19 Vaccine1件: D12114 --1件: 299
473ELEXACAFTOR1件: Elexacaftor1件: D11507 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
474Elexacaftor-tezacaftor-ivacaftor exposure3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
475Elexacaftor/tezacaftor/ivacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
476ELX----1件: 299
477ELX (VX-445)/TEZ (VX-661)/IVA (VX-770)----1件: 299
478ELX-021件: ELX-02---2件: 19, 299
479ELX/TEZ/IVA----1件: 299
480EMEA/H/C/000125----1件: 299
481Engineerd Protein Inhibitor of human Neutrophil Elastase----1件: 299
482Engineered Protein Inhibitor of human Neutrophil Elastase----1件: 299
483Ensure High Protein----1件: 299
484Ensure plus----1件: 299
485EPI-hNE4 DX-890----1件: 299
486Ergocalciferol1件: Ergocalciferol1件: D00187 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬5件: 46, 84, 96, 97, 299
487Ergocalciferol (vitamin D2)1件: Ergocalciferol1件: D00187 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
488Esomeprazole1件: Esomeprazole4件: D01984 ,
D04056 ,
D07917 ,
D09339 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬8件: 13, 46, 86, 98, 107, 113, 298, 299
489Essential amino acid intake + Leucine vs total AA supplement1件: Leucine1件: D00030 --1件: 299
490Estradiol1件: Estradiol8件: D00105 ,
D01413 ,
D01617 ,
D01953 ,
D04061 ,
D04063 ,
D04064 ,
D04065 		2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬7件: 13, 46, 49, 65, 76, 226, 299
491Estradiol 2 mg1件: Estradiol8件: D00105 ,
D01413 ,
D01617 ,
D01953 ,
D04061 ,
D04063 ,
D04064 ,
D04065 		2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299
492ETD001 multiple once daily doses----1件: 299
493ETD001 multiple twice daily doses----1件: 299
494ETD001 single dose----1件: 299
495Ethambutol1件: Ethambutol2件: D00878 ,
D07925 		--2件: 84, 299
496Ethinyl estradiol2件: Estradiol,
Ethinylestradiol		9件: D00105 ,
D00554 ,
D01413 ,
D01617 ,
D01953 ,
D04061 ,
D04063 ,
D04064 ,
D04065 		2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬3件: 46, 49, 299
497EU Orphan Designation Number EU/3/02/120----1件: 299
498EUR-1008----1件: 299
499EUR-1008 (APT-1008)----1件: 299
500EUR-1008 25,000 Units----1件: 299
501Exercise----1件: 299
502Exhaled Nitric Oxide1件: Nitric Oxide1件: D00074 --1件: 299
503EZ-2053----2件: 85, 299
504EZ-2053 5mg/kg----2件: 85, 299
505F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid)----1件: 299
506Fasenra1件: Benralizumab1件: D09874 1件: IL5RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299
507FDG-PET----1件: 299
508FDL169----1件: 299
509FDL176----1件: 299
510FDL176 & FDL169 coadministration----1件: 299
511Fenretinide1件: Fenretinide1件: D04162 2件: RARA,
RARB 💬		8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 299
512Ferinject----2件: 86, 299
513FERRIC CARBOXYMALTOSE1件: Ferric carboxymaltose1件: D08920 --4件: 86, 96, 97, 299
514Ferrous sulfate 325mg1件: Sulfate ion---1件: 299
515Finely ground flaxseed powder1件: Flax seed---1件: 299
516Fish Oil1件: Fish oil---7件: 13, 46, 49, 66, 96, 260, 299
517Flaxseed1件: Flax seed---2件: 97, 299
518FLUCLOXACILLIN1件: Flucloxacillin3件: D01249 ,
D04196 ,
D07965 		--1件: 299
519Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution1件: Flucloxacillin3件: D01249 ,
D04196 ,
D07965 		--1件: 299
520FLUCLOXACILLIN SODIUM1件: Flucloxacillin3件: D01249 ,
D04196 ,
D07965 		--1件: 299
521Flucloxicillin----1件: 299
522FluMist1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---1件: 299
523Flumist®1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---1件: 299
524Fluticasone1件: Fluticasone1件: D07981 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 98, 228, 299
525FORLAX 4 g, poudre pour solution buvable en sachet----1件: 299
526Formoterol1件: Formoterol3件: D01373 ,
D05277 ,
D07990 		1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 85, 228, 299
527Fortum----1件: 299
528Frequently Sampled Oral Glucose Tolerance Test and CGM1件: Dextrose, unspecified form---1件: 299
529FTI, AZLI----1件: 299
530Fucidin1件: Fusidic acid1件: D04281 --1件: 299
531Fucidin Tablets1件: Fusidic acid1件: D04281 --1件: 299
532FUSIDIC ACID1件: Fusidic acid1件: D04281 --1件: 299
533Fusidin----1件: 299
534G1117337----2件: 67, 299
535G914167----1件: 299
536G957389----1件: 299
537GALICAFTOR1件: Galicaftor1件: D11724 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
538Gallium nitrate2件: Gallium nitrate,
Nitrate		2件: D00940 ,
D02313 		--1件: 299
539Garlic1件: Garlic1件: D12020 --1件: 299
540Genetic: Blood or Saliva Sample Collection----1件: 299
541GENISTEIN1件: Genistein1件: D11680 --2件: 19, 299
542Genistein (Unconjugated Isoflavones 100)1件: Genistein1件: D11680 --1件: 299
543Genisteine Plus 150 mg cpl formaat 1 18,7 x 6,4 mm 438 mg----1件: 299
544Gentamicin1件: Gentamicin2件: D01063 ,
D08013 		--3件: 36, 113, 299
545Gernebcin----1件: 299
546Gernebcin 80 mg----1件: 299
547Ghrelin1件: Lenomorelin---6件: 6, 78, 193, 201, 202, 299
548GIP----1件: 299
549Giving DHA-rich supplement----1件: 299
550Glargine----1件: 299
551Glargine insulin----1件: 299
552GLP-1----1件: 299
553GLPG1837----1件: 299
554GLPG1837 dose 1----1件: 299
555GLPG1837 dose 2----1件: 299
556GLPG1837 dose 3----1件: 299
557GLPG2222----1件: 299
558GLPG2222 100 mg----1件: 299
559GLPG2222 150 mg q.d.----1件: 299
560GLPG2222 200 mg----1件: 299
561GLPG2222 300 mg q.d.----1件: 299
562GLPG2222 400 mg----1件: 299
563GLPG2222 50 mg----1件: 299
564GLPG2451 dose regimen A----1件: 299
565GLPG2451 dose regimen B----1件: 299
566GLPG2737----2件: 67, 299
567GLPG2737 single dose----1件: 299
568GLPG3067----1件: 299
569GLPG3067 single dose----1件: 299
570Glucose1件: Dextrose, unspecified form---15件: 2, 6, 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299
571Glutamine1件: L-Glutamine1件: D00015 --7件: 87, 89, 96, 97, 113, 245, 299
572Glutathione1件: Glutathione2件: D00014 ,
D00031 		--2件: 6, 299
573GLUTATHIONE SODIUM1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
574GLYCINE1件: Glycine1件: D00011 --5件: 35, 60, 86, 226, 299
575Glycine Buffer1件: Glycine1件: D00011 --1件: 299
576GlycosBio Nutritional Supplement----1件: 299
577GLYPRESSINE 1 mg/5 mL, poudre et solvant pour solution injectable (I.V.)----1件: 299
578Gold1件: Gold---43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318
579Growth hormone1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬13件: 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 299
580Growth Hormone Stimulation Test1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 299
581GS-5737----1件: 299
582GS-57451件: GS-5745---4件: 46, 96, 97, 299
583GS-9411----1件: 299
584GSH----2件: 6, 299
585GSH (Glutathione)1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
586H02 - Corticosteroidi Sistemici----1件: 299
587Helium1件: Helium1件: D04420 --3件: 228, 299, 330
588Helium-32件: Helium,
Helium He-3		1件: D04420 --2件: 228, 299
589Heparin1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬12件: 47, 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317
590Heparin 25mg inhalation powder, hard capsule1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬1件: 299
591Heparin Sodium1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬2件: 280, 299
592Heracillin----1件: 299
593HFNT during exercise----1件: 299
594HGPIV diagnosis test----1件: 299
595High dose of budesonide1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 299
596High flow nasal oxygen cannula1件: Oxygen1件: D00003 --1件: 299
597High-Dose Vitamin D31件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
598History and physical exam.----2件: 231, 299
599HMSCs----1件: 299
600HOMAR-IR diagnosis test----1件: 299
601Home Oral Glucose Tolerance Test kit1件: Dextrose, unspecified form---1件: 299
602Honey1件: Honey1件: D06776 --3件: 57, 98, 299
603HP 129Xe----1件: 299
604HP 3He----1件: 299
605Human recombinant growth hormone1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬2件: 13, 299
606Hyaluronan1件: Hyaluronic acid1件: D08043 --1件: 299
607Hydrocortisone1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬10件: 6, 41, 46, 53, 75, 78, 81, 83, 97, 299
608Hydroxychloroquine1件: Hydroxychloroquine1件: D08050 --27件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299
609Hyperglycemic clamp----1件: 299
610Hyperglycemic Clamp with concurrent GIP infusion----1件: 299
611Hyperglycemic clamp with concurrent GLP-1 infusion----1件: 299
612Hyperpolarized Helium-32件: Helium,
Helium He-3		1件: D04420 --1件: 299
613Hyperpolarized Helium-3 MRI of the chest2件: Helium,
Helium He-3		1件: D04420 --1件: 299
614Hyperpolarized Xe129----2件: 85, 299
615Hyperpolarized Xenon1件: Xenon2件: D01901 ,
D06339 		--1件: 299
616Hyperpolarized Xenon 1291件: Xenon2件: D01901 ,
D06339 		--1件: 299
617Hyperpolarized Xenon gas1件: Xenon2件: D01901 ,
D06339 		--1件: 299
618Hyperpolarized xenon-1291件: Xenon2件: D01901 ,
D06339 		--1件: 299
619Hypertonic bicarbonate----1件: 299
620HYPERTONIC SALINE----1件: 299
621Hypertonic saline (7 %) and isotonic saline (0.9%)----1件: 299
622Hypertonic saline (7%)----1件: 299
623Hypertonic saline 6% -----1件: 299
624Hypertonic Saline 7%1件: Sodium chloride1件: D02056 --1件: 299
625Hypertonic saline solution1件: Sodium chloride1件: D02056 --1件: 299
626Ibuprofen1件: Ibuprofen4件: D00126 ,
D01122 ,
D04490 ,
D06606 		2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬7件: 13, 46, 65, 107, 113, 271, 299
627Icenticaftor----1件: 299
628ICS+LABA----1件: 299
629IDPM----1件: 299
630IDPM: Inhaled Dry Powder Mannitol1件: Mannitol1件: D00062 --1件: 299
631IGE025----1件: 299
632IgY----1件: 299
633Impact----8件: 6, 13, 46, 50, 53, 96, 97, 299
634Impact-Nutridrink----1件: 299
635Increlex1件: Mecasermin2件: D03297 ,
D04870 		2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬4件: 65, 78, 96, 299
636INCRELEX*SC 1FL 4ML 10MG/ML1件: Mecasermin2件: D03297 ,
D04870 		2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 299
637Indirect Calorimetry----1件: 299
638Indium1件: Indium---3件: 28, 84, 299
639Indium-DTPA2件: Indium,
Pentetic acid		1件: D05422 --1件: 299
640INDUSIL*OS GTT FL 30MG+FL 15ML----1件: 299
641Influenza vaccination----1件: 299
642Inhaled 7% hypertonic saline (HS)----1件: 299
643Inhaled AR-501----1件: 299
644Inhaled Dry Powder Mannitol1件: Mannitol1件: D00062 --1件: 299
645Inhaled hypertonic saline (7%)----1件: 299
646Inhaled Mannitol1件: Mannitol1件: D00062 --1件: 299
647Inhaled Reduced Glutathione1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
648Inhaled SNSP113----1件: 299
649Inhaled Sodium Pyruvate----1件: 299
650Inhaled tobramycin1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
651Inhaled Vancomycin1件: Vancomycin2件: D00212 ,
D00926 		--1件: 299
652Initiation of CFTR Modulator----1件: 299
653INOmax1件: Nitric Oxide1件: D00074 --3件: 85, 294, 299
654INOmax 400ppm mol/mol inhalation gas1件: Nitric Oxide1件: D00074 --2件: 85, 299
655INS1007----2件: 44, 299
656INS1007 10 mg oral tablet----1件: 299
657INS1007 25 mg oral tablet----1件: 299
658Insulin----6件: 6, 13, 46, 75, 78, 299
659Insulin Asparte----1件: 299
660Insulin detemir1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
661Insulin detemir [rDNA origin] injection1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
662Insulin glargine1件: Insulin glargine1件: D03250 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
663Insulin Pump----1件: 299
664Insuline humaine recombinante----1件: 299
665Interferon Gamma1件: Interferon Gamma---8件: 18, 65, 85, 107, 228, 299, 301, 326
666INTERFERON GAMMA-1B2件: Interferon Gamma,
Interferon gamma-1b		1件: D00747 2件: IFNGR1,
IFNGR2 💬		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬7件: 18, 65, 85, 228, 299, 301, 326
667Intermittent, short infusion Cefepime1件: Cefepime1件: D02376 --1件: 299
668Intermittent, short infusion Ceftazidime1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
669Intermittent, short infusion Meropenem1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
670Intermittent, short infusion Piperacillin tazobactam2件: Piperacillin,
Tazobactam		4件: D00466 ,
D00660 ,
D02251 ,
D08380 		--1件: 299
671Intermittent, short infusion Ticarcillin-clavulanate2件: Clavulanic acid,
Ticarcillin		2件: D07711 ,
D08593 		--1件: 299
672Inulin1件: Inulin1件: D00171 --2件: 96, 299
673IONIS-ENaCRx----1件: 299
674ISOTONIC SALINE----1件: 299
675Isotonic saline 0.9%1件: Sodium chloride1件: D02056 --1件: 299
676Itraconazole1件: Itraconazole1件: D00350 --5件: 3, 65, 96, 227, 299
677Itraconazole/voriconazole2件: Itraconazole,
Voriconazole		2件: D00350 ,
D00578 		--1件: 299
678IV amikacin1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
679IV ceftazidime1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
680IV glucose tolerance test1件: Dextrose, unspecified form---1件: 299
681IV meropenem1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
682IV piperacillin-tazobactam2件: Piperacillin,
Tazobactam		4件: D00466 ,
D00660 ,
D02251 ,
D08380 		--1件: 299
683IV ticarcillin-clavulanate2件: Clavulanic acid,
Ticarcillin		2件: D07711 ,
D08593 		--1件: 299
684IV tobramycin1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
685IV vancomycin hydrochloride1件: Vancomycin2件: D00212 ,
D00926 		--1件: 299
686IVA----1件: 299
687IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
688Ivacaftor (proposed INN)1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
689Ivacaftor 125mg tablet1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
690Ivacaftor 150 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
691Ivacaftor 150 mg or 250 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
692Ivacaftor 25 mg/75 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
693IVACAFTOR 59,5mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
694IVACAFTOR 59.5mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
695Ivacaftor 75 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
696Ivacaftor 75 mg/150 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
697IVACAFTOR 75mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
698Ivacaftor Exposed1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
699Ivacaftor or elexacaftor/tezacaftor/ivacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
700Ivacaftor+lumacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
701Ivacaftor/Ataluren2件: Ataluren,
Ivacaftor		2件: D09323 ,
D09916 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
702Ivacaftor/Kalydeco1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
703Ivacaftor/Trikafta1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
704J01GB01----1件: 299
705JBT-101----4件: 49, 50, 51, 299
706JBT-101 (lenabasum)----1件: 299
707Kaftrio1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
708Kalydeco1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
709Kalydeco 150 mg film-c1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
710Kalydeco 150 mg film-coated tablets1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
711Kalydeco 150mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
712KB0011件: KB001---1件: 299
713KB001-A1件: KB001---1件: 299
714Ketone Monoester----1件: 299
715Kineret1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬9件: 28, 41, 46, 49, 65, 106, 107, 266, 299
716Klacid----1件: 299
717Kreon 25 000----1件: 299
718Kreon 25,000 Units----1件: 299
719Kreon 25000----2件: 298, 299
720KREON de Liberación Inmediata----1件: 299
721KREON N 25000----1件: 299
722Kreon® 25,000----1件: 299
723L-alanine1件: Alanine1件: D00012 --1件: 299
724L-arginine1件: Arginine1件: D02982 --3件: 46, 113, 299
725L-Glutamine1件: L-Glutamine1件: D00015 --2件: 113, 299
726L-Lysine N acetylcysteinate1件: Lysine1件: D02304 --1件: 299
727L-Lysine N-acetylcysteinate1件: Lysine1件: D02304 --1件: 299
728L-Lysine- N-acetylcysteinate1件: Lysine1件: D02304 --1件: 299
729L-Lysine-N-acetyl-L-cysteinate1件: Lysine1件: D02304 --1件: 299
730L-Lysine-N-acetylcysteinate1件: Lysine1件: D02304 --1件: 299
731LABA/LAMA----1件: 299
732Lactic acid1件: Lactic acid1件: D00111 --2件: 265, 299
733Lactic acid producing organisms1件: Lactic acid1件: D00111 --1件: 299
734Lactizole nebulization----1件: 299
735Lactobacillus1件: Lactobacillus delbrueckii bulgaricus---5件: 6, 46, 51, 97, 299
736LACTOBACILLUS REUTERI1件: Lactobacillus reuteri---2件: 97, 299
737Lactobacillus rhamnosus1件: Lactobacillus delbrueckii bulgaricus---1件: 299
738Lactobacillus rhamnosus GG1件: Lactobacillus delbrueckii bulgaricus---1件: 299
739Lansoprazole1件: Lansoprazole1件: D00355 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬7件: 63, 71, 85, 98, 166, 222, 299
740Lantus 100 units/ml solution for injection in a cartridge----1件: 299
741LANTUS*SC 5CAR3ML100UI/ML1件: Insulin glargine1件: D03250 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
742Lantus® 100 Units/ml solution for injection in a vial. Lantus® 100 Units/ml solution for injection in a cartridge. Lantus® 100 Units/ml solution for injection in a pre-filled pen----1件: 299
743LAU-7b----1件: 299
744Lefamulin1件: Lefamulin1件: D11631 --1件: 299
745Lenabasum----3件: 50, 51, 299
746Lenabasum 20 mg----3件: 50, 51, 299
747Lenabasum 5 mg----3件: 50, 51, 299
748Leucine1件: Leucine1件: D00030 --11件: 5, 6, 7, 19, 65, 96, 97, 127, 283, 284, 299
749Levemir1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
750Levemir 100 U/ml solution for injection in a cartridge, Levemir 100 U/ml solution for injection in a pre-filled pen1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
751Levemir FlexPen1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
752Levemir insulin1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
753Levemir Penfill1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
754Levofloxacin1件: Levofloxacin2件: D00588 ,
D08120 		--4件: 46, 53, 84, 299
755LEVOFLOXACIN HEMIHYDRATE1件: Levofloxacin2件: D00588 ,
D08120 		--1件: 299
756Levofloxacin Kabi1件: Levofloxacin2件: D00588 ,
D08120 		--1件: 299
757Linez----1件: 299
758LINEZOLID1件: Linezolid1件: D00947 --1件: 299
759Linoleic acid1件: Linoleic acid---4件: 2, 5, 13, 299
760Linoleic acid supplementation1件: Linoleic acid---1件: 299
761LIPASA----1件: 299
762LIPASE----2件: 298, 299
763Lipase CLEC----1件: 299
764LIPASE LIP2----1件: 299
765Lipase Lip2 from Yarrowia lipolytica----1件: 299
766Lipitor1件: Atorvastatin3件: D00258 ,
D00887 ,
D07474 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 51, 96, 299
767Liposomal Amikacin1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
768Liposomal Amikacin (Arikace TM)1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
769Liposomal Amikacin (Arikace™)1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
770Liposomal amikacin for inhalation1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
771Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer.1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
772Liposomal amphotericin B (Ambisome®)1件: Amphotericin B1件: D00203 --1件: 299
773Liprotamasa----1件: 299
774Liprotamase----2件: 298, 299
775Liprotamase Powder for Oral Solution----1件: 299
776Loestrin (norethindrone acetate and ethinyl estradiol)4件: Acetate,
Estradiol,
Ethinylestradiol,
Norethisterone		11件: D00105 ,
D00182 ,
D00554 ,
D00953 ,
D01413 ,
D01617 ,
D01953 ,
D04061 ,
D04063 ,
D04064 ,
D04065 		3件: ESR1,
ESR2,
PGR 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299
777Lonodelestat----1件: 299
778Losartan1件: Losartan2件: D00357 ,
D08146 		1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299
779LU 70274----1件: 299
780LUBIPROSTONE1件: Lubiprostone1件: D04790 1件: CLCN2 💬1件: Mineral absorption 💬4件: 6, 13, 290, 299
781Lucinactant1件: Lucinactant1件: D04792 --1件: 299
782Lucinactant first1件: Lucinactant1件: D04792 --1件: 299
783LUM----1件: 299
784LUM/IVA----1件: 299
785LUM/IVA fixed-dose combination----1件: 299
786LUMACAFTOR1件: Lumacaftor1件: D10134 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
787Lumacaftor / ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
788Lumacaftor plus Ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
789Lumacaftor Plus Ivacaftor Combination2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
790Lumacaftor, Ivacaftor Drug Combination2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
791Lumacaftor-ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
792Lumacaftor-Ivacaftor treatment2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
793Lumacaftor/Ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
794Lumacaftor/ivacaftor 100mg/125mg tablets2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
795Lumacaftor/ivacaftor 200mg/125mg2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
796Lumacaftor/ivacaftor 200mg/125mg tablets2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
797Lumacaftor/ivacaftor 200mg/83mg tablet2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
798Lung Clearance Index----1件: 299
799Lym-X-Sorb powder----1件: 299
800Lysine1件: Lysine1件: D02304 --4件: 13, 97, 228, 299
801Lysomucil 10 %----1件: 299
802Macroduct sweat stimulator----1件: 299
803Macrogol1件: Polyethylene glycol1件: D03370 --1件: 299
804Macrogol 40001件: Polyethylene glycol1件: D03370 --1件: 299
805MAG-DHA----1件: 299
806Magnetic Resonance Imaging----7件: 6, 13, 19, 22, 34, 205, 299
807Mannite1件: Mannitol1件: D00062 --1件: 299
808Mannitol1件: Mannitol1件: D00062 --7件: 6, 13, 28, 60, 96, 113, 299
809Mannitol + pulmozyme2件: Dornase alfa,
Mannitol		2件: D00062 ,
D03896 		--1件: 299
810Mannitol inhalation powder1件: Mannitol1件: D00062 --1件: 299
811Manuka honey sinus rinse1件: Honey1件: D06776 --1件: 299
812Matched isoglycemic clamp----1件: 299
813Mecasermin1件: Mecasermin2件: D03297 ,
D04870 		2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬5件: 78, 96, 168, 265, 299
814MEDI-563----5件: 44, 45, 98, 162, 299
815Medical Grade Oxygen1件: Oxygen1件: D00003 --1件: 299
816Melphalan1件: Melphalan1件: D00369 --15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299
817Menadiol Diphosphate1件: Menadiol diphosphate1件: D08176 --1件: 299
818Menadiol sodium diphosphate1件: Kappadione1件: D04908 --1件: 299
819MEROPENEM1件: Meropenem2件: D02222 ,
D08185 		--2件: 60, 299
820Meropenem Fresenius Kabi1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
821Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
822Meropenem Infusion1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
823MEROPENEM TRIHYDRATE1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
824Mesenchymal stem cells----11件: 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299
825Metformin1件: Metformin2件: D00944 ,
D04966 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬24件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
826METFORMIN HYDROCHLORIDE1件: Metformin2件: D00944 ,
D04966 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬5件: 81, 158, 265, 299, 301
827Metformine1件: Metformin2件: D00944 ,
D04966 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬3件: 46, 81, 299
828Metformine HCL 500 PCH1件: Metformin2件: D00944 ,
D04966 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 299
829MIGLUSTAT1件: Miglustat1件: D05032 1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 19, 256, 299
830Minocycline1件: Minocycline2件: D00850 ,
D05045 		--13件: 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299
831Minocycline Hydrochloride1件: Minocycline2件: D00850 ,
D05045 		--4件: 13, 201, 206, 299
832MMF----15件: 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 162, 222, 224, 226, 299
833Modified lipid formulation----1件: 299
834Modified Oral Glucose Tolerance Test (50g 4-hours)1件: Dextrose, unspecified form---1件: 299
835Molgramostim1件: Molgramostim1件: D05066 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬3件: 97, 229, 299
836Molgramostim nebulizer solution1件: Molgramostim1件: D05066 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 299
837MOLI 1901----1件: 299
838Moli 1901 (2622U90, duramycin)1件: Lancovutide---1件: 299
839Moli1901----1件: 299
840Moli1901 (2622U90, duramycin)1件: Lancovutide---1件: 299
841MONITOR1件: Methamidophos---20件: 2, 11, 13, 19, 28, 46, 49, 58, 65, 70, 81, 85, 86, 98, 113, 118, 129, 298, 299, 300
842Moxifloxacin1件: Moxifloxacin2件: D00874 ,
D08237 		--9件: 2, 6, 46, 49, 85, 86, 113, 240, 299
843Moxifloxacin Hydrochloride1件: Moxifloxacin2件: D00874 ,
D08237 		--2件: 113, 299
844MP-376----1件: 299
845MP-376 (Levofloxacin Solution for Inhalation)1件: Levofloxacin2件: D00588 ,
D08120 		--1件: 299
846MRI with PFP----1件: 299
847MRT5005----1件: 299
848MS1819----2件: 298, 299
849MS1819-SD1件: MS-1819---2件: 298, 299
850MSI-1995----1件: 299
851MTT----1件: 299
852Mucoid exopolysaccharide P. aeruginosa immune globulin IV----1件: 299
853Mucolysin----1件: 299
854Mucomyst1件: Acetylcysteine1件: D00221 --1件: 299
855Multienzymes (lipase, protease etc.)----2件: 298, 299
856Mupirocin1件: Mupirocin2件: D01076 ,
D02195 		--2件: 227, 299
857Mupirocin Intranasal Creme1件: Mupirocin2件: D01076 ,
D02195 		--1件: 299
858N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide----1件: 299
859N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide----1件: 299
860N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide----1件: 299
861N-acetylcystein----1件: 299
862N-Acetylcysteine1件: Acetylcysteine1件: D00221 --11件: 6, 13, 19, 20, 49, 58, 85, 111, 164, 299, 337
863N-acetylcysteine (NAC)1件: Acetylcysteine1件: D00221 --3件: 34, 51, 299
864N6022----1件: 299
865N91115----1件: 299
866NAC----5件: 34, 51, 85, 90, 299
867Nacystelyn----1件: 299
868Nacystelyn®----1件: 299
869NAL----2件: 6, 299
870Nasal Aztreonam1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
871Navocaftor----1件: 299
872NEB/01-07----1件: 299
873Nebcin----1件: 299
874Nebcin (tobramycin)1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
875Nebcinal----1件: 299
876Nebcinal Tobi----1件: 299
877NEBCINE----1件: 299
878Nebulization of Amikacin during NIV (RR: 15 cycles/minute)1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
879Nebulization of Amikacin during NIV (RR: 25 cycles/minute)1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
880Nebulization tobramycin1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
881Nexium1件: Esomeprazole4件: D01984 ,
D04056 ,
D07917 ,
D09339 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 299
882Nexium 201件: Esomeprazole4件: D01984 ,
D04056 ,
D07917 ,
D09339 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 299
883Nitrate1件: Nitrate1件: D02313 --3件: 58, 113, 299
884Nitric Oxide1件: Nitric Oxide1件: D00074 --8件: 46, 85, 86, 98, 210, 251, 294, 299
885Nitric Oxide 160 ppm1件: Nitric Oxide1件: D00074 --1件: 299
886Nitric Oxide for inhalation1件: Nitric Oxide1件: D00074 --2件: 86, 299
887Nitrite1件: Nitrite---3件: 58, 86, 299
888Nitrogen1件: Nitrogen1件: D00083 --6件: 5, 6, 17, 171, 211, 299
889NO----12件: 6, 13, 46, 58, 62, 86, 96, 97, 222, 226, 299, 321
890Nocturnal oxygen , nocturnal bi-level positive pressure ventilation1件: Oxygen1件: D00003 --1件: 299
891Non invasive ventilation----1件: 299
892None----16件: 6, 46, 51, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299
893None assigned1件: Interleukin-1 alpha, human recombinant---2件: 231, 299
894Noninvasive ventilation----1件: 299
895Norethindrone1件: Norethisterone2件: D00182 ,
D00953 		1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬4件: 13, 46, 49, 299
896Norgestimate1件: Norgestimate1件: D05209 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 299
897Normal Saline----18件: 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299
898Normal saline IV, salt tablets----1件: 299
899Normal saline solution1件: Sodium chloride1件: D02056 --1件: 299
900Normal saline:----1件: 299
901Norvir1件: Ritonavir1件: D00427 --2件: 265, 299
902Norvir 100 mg film-coated tablets----1件: 299
903Novamin----1件: 299
904Novo Rapid----1件: 299
905Novo Rapid Insulin (Novonordisk)----1件: 299
906Novolog insulin----1件: 299
907NovoNorm 0.5 mg----1件: 299
908NovoNorm 1 mg----1件: 299
909NovoNorm 2 mg----1件: 299
910Novorapid / humalog short acting insulin----1件: 299
911NovoRapid 100 U/ml, solution for injection in a vial. NovoRapid Penfill 100 U/ml, solution for injection in a cartridge. NovoRapid FlexPen 100 U/ml, solution for injection in a pre-filled pen.----1件: 299
912NovoRapid Aspartate----1件: 299
913Noxafil1件: Posaconazole1件: D02555 --3件: 60, 65, 299
914NOXAFIL - 40 mg/ml oral suspension1件: Posaconazole1件: D02555 --1件: 299
915NOXAFIL - 40 MG/ML SOSPENSIONE ORALE USO ORALE FLACONE (VETRO) 105 ML 1 FLACONE1件: Posaconazole1件: D02555 --1件: 299
916NOXAFIL - oral suspension 40 mg/ml1件: Posaconazole1件: D02555 --1件: 299
917Noxafil 100 mg1件: Posaconazole1件: D02555 --1件: 299
918Noxafil 100 mg Tablets Gastro-Resistant1件: Posaconazole1件: D02555 --1件: 299
919Noxafil®1件: Posaconazole1件: D02555 --2件: 60, 299
920NR----1件: 299
921Nutridrink-Impact----1件: 299
922Nutropin AQ----4件: 78, 134, 193, 299
923Nutropin AQ [somatropin (DNA origin) injection]1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 299
924OGT 918----2件: 19, 299
925Oleic Acid1件: Oleic Acid1件: D02315 --2件: 13, 299
926Oleic acid supplementation1件: Oleic Acid1件: D02315 --1件: 299
927OligoG----1件: 299
928OligoG (60 mg/ml)----1件: 299
929OLIGOG CF-5/20----1件: 299
930OligoG CF-5/20 - 17.5 mg----1件: 299
931OligoG CF-5/20, 17,5 mg, Hartkapsel mit Pulver zur Inhalation----1件: 299
932OligoG CF/20 - 27.5 mg----1件: 299
933OligoG CF/20 - 37.5 mg----1件: 299
934OligoG CF/20, 27,5 mg, Hartkapsel mit Pulver zur Inhalation----1件: 299
935OligoG CF/20, 37,5 mg, Hartkapsel mit Pulver zur Inhalation----1件: 299
936OligoG DPI----1件: 299
937OligoG Dry powder for inhalation----1件: 299
938OligoG-CF5/20, Alginate oligosaccharide (G-block) fragment1件: Alginic acid1件: D02324 --1件: 299
939Oligomer of Sodium Alginate1件: Alginic acid1件: D02324 --1件: 299
940Omadacycline1件: Omadacycline1件: D09647 --1件: 299
941Omadacycline Injection [Nuzyra]1件: Omadacycline1件: D09647 --1件: 299
942Omadacycline Oral Tablet [Nuzyra]1件: Omadacycline1件: D09647 --1件: 299
943OMALIZUMAB1件: Omalizumab1件: D05251 1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299
944Omega 3----3件: 13, 53, 299
945Omega 3 Premium----1件: 299
946Omega-31件: Omega-3 fatty acids---7件: 13, 46, 49, 66, 79, 96, 299
947Omega-3 triglycerides1件: Omega-3 fatty acids---1件: 299
948OMEGA-3-ACID TRIGLYCERIDES1件: Omega-3 fatty acids---1件: 299
949Omeprazole1件: Omeprazole4件: D00455 ,
D01207 ,
D05259 ,
D05261 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬16件: 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299
950Omeprazole 40mg Capsule1件: Omeprazole4件: D00455 ,
D01207 ,
D05259 ,
D05261 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 299
951Once-daily insulin detemir1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
952Oral Aztreonam1件: Aztreonam2件: D00240 ,
D06558 		--1件: 299
953Oral ciprofloxacin1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
954Oral ciprofloxacin plus inhaled colistin2件: Ciprofloxacin,
Colistin		4件: D00186 ,
D02138 ,
D02216 ,
D07746 		--1件: 299
955Oral Glucose Tolerance Test1件: Dextrose, unspecified form---1件: 299
956Oral Glucose Tolerance test (75g 2-hour)1件: Dextrose, unspecified form---1件: 299
957Oral Glutathione1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
958Oral reduced l-glutathione1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
959Oral roflumilast1件: Roflumilast1件: D05744 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 299
960Orkambi1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
961Orkambi 100 mg/125 mg film-coated tablets1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
962Orkambi 200 mg/125 mg film-coated tablets1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
963Orkambi: contains lumacaftor and ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
964Orkambi®1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
965Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg3件: Estradiol,
Ethinylestradiol,
Norgestimate		10件: D00105 ,
D00554 ,
D01413 ,
D01617 ,
D01953 ,
D04061 ,
D04063 ,
D04064 ,
D04065 ,
D05209 		3件: ESR1,
ESR2,
PGR 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299
966OSCN-----1件: 299
967Oseltamivir1件: Oseltamivir2件: D00900 ,
D08306 		--2件: 97, 299
968Osmohale----1件: 299
969Other non-sponsor pancreatic enzyme replacement therapy----1件: 299
970Other respiratory system products----1件: 299
971Other: A-STEP----1件: 299
972Other: A-STEP (New Protocol)----1件: 299
973Other: Absorptive clearance scan----1件: 299
974Other: Air - oxygen1件: Oxygen1件: D00003 --1件: 299
975Other: Autogenic drainage----1件: 299
976Other: Balance1件: Isoxaflutole---3件: 6, 13, 299
977Other: Blood glucose results1件: Dextrose, unspecified form---1件: 299
978Other: blood sample----1件: 299
979Other: Comparator: CPET cycle ergometer (Gold Standard)1件: Gold---1件: 299
980Other: Continuation of dornase alfa (dnase)1件: Dornase alfa1件: D03896 --1件: 299
981Other: Continuation of hypertonic saline (HS)----1件: 299
982Other: Diagnostics for glucose tolerance with 3 different methods.1件: Dextrose, unspecified form---1件: 299
983Other: Discontinuation of dornase alfa (dnase)1件: Dornase alfa1件: D03896 --1件: 299
984Other: Discontinuation of hypertonic saline (HS)----1件: 299
985Other: Exercise capacity----1件: 299
986Other: Fruit juice----1件: 299
987Other: Glucose -potentiated arginine (GPA) stimulation tests2件: Arginine,
Dextrose, unspecified form		1件: D02982 --1件: 299
988Other: Glucose profile for 2 weeks1件: Dextrose, unspecified form---1件: 299
989Other: glucose solution at a dose of 1.75 g/kg (up to a maximum of 75 g) for the OGTT and glucose solution at a dose of 0.5 g/kg (up to a maximum of 35 g) was injected in 2.5-3 min for the IGTT1件: Dextrose, unspecified form---1件: 299
990Other: Hepatic elastography----1件: 299
991Other: High Glycemic Index Meal----1件: 299
992Other: Hyperpolarized Xenon MRI1件: Xenon2件: D01901 ,
D06339 		--1件: 299
993Other: Hypoglycemic Clamp----1件: 299
994Other: Impact Peptide 1.5----1件: 299
995Other: Inhalable Hypertonic saline 7%----1件: 299
996Other: Inhalable Hypertonic saline 7% + Hyaluronan 0.1%1件: Hyaluronic acid1件: D08043 --1件: 299
997Other: Liquid Meal Test (Carbohydrate-rich)----1件: 299
998Other: Liquid Meal Test (Fat-rich)----1件: 299
999Other: Liquid Meal Test (Mixed)----1件: 299
1000Other: Low Glycemic Index Meal----1件: 299
1001Other: measure of endothelial function----1件: 299
1002Other: Mixed meal test evaluation test arm----1件: 299
1003Other: Mixed Meal Tolerance Test----1件: 299
1004Other: Muscle oxygenation----1件: 299
1005Other: No doxycycline1件: Doxycycline5件: D00307 ,
D02129 ,
D03903 ,
D03904 ,
D07876 		--1件: 299
1006Other: No pancreatic enzyme replacement therapy----1件: 299
1007Other: Non-hormonal period----1件: 299
1008Other: OGTT----1件: 299
1009Other: On-demand treatment----1件: 299
1010Other: Ophthalmologic examinations----1件: 299
1011Other: Oral Glucose tolerance test1件: Dextrose, unspecified form---3件: 160, 195, 299
1012Other: Oral Glucose Tolerance Test (OGTT) assessment arm1件: Dextrose, unspecified form---1件: 299
1013Other: Oxygen - Air1件: Oxygen1件: D00003 --1件: 299
1014Other: Pentadecanoic acid (PA) and Triheptadecanoin (THA)----1件: 299
1015Other: quercetin1件: Quercetin---1件: 299
1016Other: Reaction Time and Postural Control----1件: 299
1017Other: routine therapy----1件: 299
1018Other: Sham Comparator----1件: 299
1019Other: Sputum Sample----1件: 299
1020Other: Stool Sample----2件: 6, 299
1021Other: Technetium [Tc-99m] sulfur colloid and Indium [In-111] DTPA2件: Indium,
Pentetic acid		1件: D05422 --1件: 299
1022Other: Test Soda----1件: 299
1023Other: Tobacco questionnaire1件: Tobacco leaf---1件: 299
1024Other: Tobramycin time of administration1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1025Other: Usual care----3件: 46, 107, 299
1026Oxygen1件: Oxygen1件: D00003 --20件: 6, 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 168, 193, 226, 271, 294, 299, 330
1027P-1037----1件: 299
1028PAAG15----1件: 299
1029Pancreas Powder----1件: 299
1030Pancrease----1件: 299
1031PANCREASE MT----1件: 299
1032Pancrease MT 10.5, or MT 21----1件: 299
1033PANCREASLIPASE----1件: 299
1034Pancreatin1件: Pancrelipase1件: D05349 --2件: 298, 299
1035PANCREATIN (PAncreas Powder)1件: Pancrelipase1件: D05349 --1件: 299
1036PANCREATINA----1件: 299
1037PANCREATINA (Páncreas Polvo----1件: 299
1038PANCREATINA (Páncreas Polvo)----1件: 299
1039PANCREAZE----1件: 299
1040PANCREAZE®----1件: 299
1041PANCRECARB® (pancrelipase)1件: Pancrelipase1件: D05349 --1件: 299
1042Pancrelipase1件: Pancrelipase1件: D05349 --2件: 298, 299
1043PANCRELIPASE AMYLASE1件: Pancrelipase1件: D05349 --1件: 299
1044Pancrelipase Delayed Release1件: Pancrelipase1件: D05349 --1件: 299
1045Pancrelipase Delayed Release Capsule1件: Pancrelipase1件: D05349 --2件: 298, 299
1046Pancrelipase Microtablets1件: Pancrelipase1件: D05349 --1件: 299
1047Pancrelipase with bicarbonate1件: Pancrelipase1件: D05349 --1件: 299
1048Pancrelipase/Pancreas Powder1件: Pancrelipase1件: D05349 --2件: 298, 299
1049Pankreatin----1件: 299
1050PANZYTRAT 25000----1件: 299
1051Panzytrat® 25,000----1件: 299
1052Panzytrat® ok----1件: 299
1053PARI eFlow nebulizer system----1件: 299
1054PBI4050----2件: 85, 299
1055PC945----1件: 299
1056PEG----12件: 6, 13, 41, 46, 65, 78, 96, 97, 140, 144, 240, 299
1057Perfluorinated gas/oxygen mixture1件: Oxygen1件: D00003 --1件: 299
1058Perform three multiple breath nitrogen washout tests (N2-MBW-test)1件: Nitrogen1件: D00083 --1件: 299
1059PERTZYE----1件: 299
1060PFP----1件: 299
1061PFP and SF6 Human Lung Coil----1件: 299
1062PFT----3件: 89, 113, 299
1063PGM169/GL67A----1件: 299
1064PHENYLBUTYRATE1件: Phenylbutyric acid---12件: 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338
1065Phosphate1件: Phosphate ion---33件: 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299
1066Physiologic serum nebulized nasally----1件: 299
1067Physiological solution----1件: 299
1068Physiotherapy, exercise, percutaneous gastrostomy feeds----1件: 299
1069Pilocarpine1件: Pilocarpine3件: D00525 ,
D02200 ,
D05478 		2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 53, 299
1070Pilocarpine Iontophoresis1件: Pilocarpine3件: D00525 ,
D02200 ,
D05478 		2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299
1071Pilocarpine microneedle patch1件: Pilocarpine3件: D00525 ,
D02200 ,
D05478 		2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299
1072Pilocarpine Nitrate 5%2件: Nitrate,
Pilocarpine		4件: D00525 ,
D02200 ,
D02313 ,
D05478 		2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299
1073Pioglitazone1件: Pioglitazone2件: D00945 ,
D08378 		1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
1074PIPERACILLIN1件: Piperacillin3件: D00466 ,
D02251 ,
D08380 		--1件: 299
1075PIPERACILLIN SODIUM1件: Piperacillin3件: D00466 ,
D02251 ,
D08380 		--1件: 299
1076Piperacillin sodium , tazobactam sodium2件: Piperacillin,
Tazobactam		4件: D00466 ,
D00660 ,
D02251 ,
D08380 		--1件: 299
1077Piperacillin with Tazobactam (tazocin)2件: Piperacillin,
Tazobactam		4件: D00466 ,
D00660 ,
D02251 ,
D08380 		--1件: 299
1078Piperacillin-tazobactam combination product2件: Piperacillin,
Tazobactam		4件: D00466 ,
D00660 ,
D02251 ,
D08380 		--1件: 299
1079Piperacillin/Tazobactam2件: Piperacillin,
Tazobactam		4件: D00466 ,
D00660 ,
D02251 ,
D08380 		--1件: 299
1080Piperacillin/Tazobactam Kabi - Fresenius Kabi Austria2件: Piperacillin,
Tazobactam		4件: D00466 ,
D00660 ,
D02251 ,
D08380 		--1件: 299
1081Piperacilline/Tazobactam Fresenius Kabi 2 g/0,25 g poeder voor oplossing voor infusie1件: Tazobactam1件: D00660 --1件: 299
1082Piperacilline/Tazobactam Fresenius Kabi 4 g/0,5 g poeder voor oplossing voor infusie1件: Tazobactam1件: D00660 --1件: 299
1083PL 0010/0211----1件: 299
1084PLERIXAFOR1件: Plerixafor1件: D08971 1件: CXCR4 💬12件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬5件: 20, 51, 65, 285, 299
1085Plerixafor mobilization of autologous CD117 stem cells1件: Plerixafor1件: D08971 1件: CXCR4 💬12件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬1件: 299
1086PO azithromycin1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 299
1087PO ciprofloxacin1件: Ciprofloxacin2件: D00186 ,
D02216 		--1件: 299
1088POL6014----1件: 299
1089POL7080----1件: 299
1090Polyethylene glycol1件: Polyethylene glycol1件: D03370 --7件: 6, 78, 96, 97, 235, 276, 299
1091Polyethylene Glycol 33501件: Polyethylene glycol1件: D03370 --2件: 96, 299
1092Porcine (pig) PERT----1件: 299
1093Porcine PERT----1件: 299
1094Posaconazole1件: Posaconazole1件: D02555 --4件: 60, 65, 96, 299
1095Posaconazole 100 MG [Noxafil]1件: Posaconazole1件: D02555 --1件: 299
1096Posaconazole 40 MG/ML1件: Posaconazole1件: D02555 --1件: 299
1097POSACONAZOLO----1件: 299
1098Positive expiratory pressure----1件: 299
1099PPI treatment----1件: 299
1100PREDNISOLONE1件: Prednisolone8件: D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬43件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
1101Prednisone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331
1102PREFOLIC*30CPR GASTROR 15MG----1件: 299
1103Prograft capsules----1件: 299
1104Prolastin----3件: 231, 298, 299
1105Prolastin (drug)----1件: 299
1106Promixin----1件: 299
1107Promixin 1 million International Units (IU) Powder for Nebuliser Solution----1件: 299
1108PROMIXIN*NEBUL 30MONOD 1MUI----1件: 299
1109Promixin, 1 million International Units (IU) Powder for Nebuliser Solution----1件: 299
1110Promixin,1 millón de Unidades Internacionales,polvo para solución para inhalación por nebulizador----1件: 299
1111Promixin/Tadim----1件: 299
1112PROTEASA----1件: 299
1113PROTEASE----1件: 299
1114PsAer IgY----1件: 299
1115PTC-0161480----2件: 246, 299
1116PTC-124----2件: 246, 299
1117PTC-C124----2件: 246, 299
1118PTC124----4件: 19, 113, 246, 299
1119PTI-4281件: PTI-428---1件: 299
1120PTI-8011件: PTI-801---1件: 299
1121PTI-808----1件: 299
1122Pulmaquin®----1件: 299
1123Pulmonary Function Testing----3件: 2, 228, 299
1124Pulmonary function testing.----2件: 231, 299
1125Pulmozyme1件: Dornase alfa1件: D03896 --1件: 299
1126Pulmozyme (dornase alfa)1件: Dornase alfa1件: D03896 --1件: 299
1127Pulmozyme (Dornase alpha)1件: Dornase alfa1件: D03896 --1件: 299
1128Pulmozyme single use ampule1件: Dornase alfa1件: D03896 --1件: 299
1129Pulmozyme®1件: Dornase alfa1件: D03896 --1件: 299
1130PUR118----1件: 299
1131QAU145----1件: 299
1132QBW251----1件: 299
1133QBW276----1件: 299
1134QBW276 1500mcg----1件: 299
1135QBW276 300mcg----1件: 299
1136QBW276 Succinate----1件: 299
1137QR-010----1件: 299
1138Quercetin1件: Quercetin---5件: 84, 85, 192, 285, 299
1139R03AC02----1件: 299
1140R03CC02----1件: 299
1141R05C B01----1件: 299
1142Radiation: MRI Pancreas and Liver----1件: 299
1143Radiolabelled OligoG CF-5/20 6% Solution----1件: 299
1144Radiolabelled OligoG CF-5/20 6% Solution for Nebulisation----1件: 299
1145Radiolabelled OligoG CF-5/20 DPI----1件: 299
1146Radiolabelled OligoG CF-5/20 Dry Powder for Inhalation (DPI)----1件: 299
1147Rapeglinide----1件: 299
1148RAVICTI1件: Glycerol phenylbutyrate1件: D10127 --2件: 251, 299
1149Ravicti high dose1件: Glycerol phenylbutyrate1件: D10127 --1件: 299
1150Ravicti low dose1件: Glycerol phenylbutyrate1件: D10127 --1件: 299
1151Recombiant human Desoxyribonuclease ( rhDNase)1件: Desoxyribonuclease---1件: 299
1152Recombinant Human DNase (Pulmozyme)1件: Dornase alfa1件: D03896 --1件: 299
1153Recombinant human IGF-1----2件: 78, 299
1154Recombinant humanized monoclonal antibody omalizumab to IgE1件: Omalizumab1件: D05251 1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299
1155Recombinant truncated SPINT2 protease inhibitor----1件: 299
1156Red Blood Cell Zn----1件: 299
1157Reduced Glutathione1件: Glutathione2件: D00014 ,
D00031 		--2件: 6, 299
1158Reduced glutathione sodium salt1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
1159Release1件: Manganese citrate---12件: 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299
1160RELiZORB (immobilized lipase) cartridge----1件: 299
1161Repaglinide1件: Repaglinide1件: D00594 2件: ABCC8,
KCNJ11 💬		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬3件: 6, 21, 299
1162Repaglinide and Insulin1件: Repaglinide1件: D00594 2件: ABCC8,
KCNJ11 💬		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 299
1163Reparixin1件: Reparixin1件: D08984 2件: CXCR1,
CXCR2 💬		7件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬2件: 298, 299
1164Resunab, ajulemic acid, anabasum1件: Ajulemic acid1件: D11312 1件: CNR2 💬1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299
1165Resveratrol1件: Resveratrol---6件: 2, 8, 18, 89, 113, 299
1166RhBSSL1件: Bucelipase alfa---1件: 299
1167RhDNAse----1件: 299
1168Rifampicin1件: Rifampicin1件: D00211 --6件: 6, 17, 46, 93, 299, 338
1169Rifampin1件: Rifampicin1件: D00211 --5件: 6, 13, 84, 86, 299
1170Rimactan----1件: 299
1171RIOCIGUAT1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬6件: 51, 84, 86, 88, 225, 299
1172Riociguat (Adempas, BAY63-2521)1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬4件: 51, 86, 88, 299
1173Roflumilast1件: Roflumilast1件: D05744 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 84, 299
1174Roflumilast Oral Tablet1件: Roflumilast1件: D05744 4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 299
1175Roscovitine----1件: 299
1176Rosuvastatin1件: Rosuvastatin2件: D01915 ,
D08492 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬11件: 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299
1177ROSUVASTATIN CALCIUM2件: Calcium,
Rosuvastatin		2件: D01915 ,
D08492 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬4件: 49, 79, 97, 299
1178Roxithromycin1件: Roxithromycin1件: D01710 --2件: 46, 299
1179RPL554----1件: 299
1180RPS 2505----2件: 246, 299
1181Répaglinide----1件: 299
1182S-1226----1件: 299
1183Salbutamol1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬9件: 3, 11, 49, 85, 86, 111, 228, 256, 299
1184Salbutamol-ratiopharm® N metered-dose aerosol inhaler1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1185Salbutamol-ratiopharm® N metereddose aerosol inhaler1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1186Salbutamolo----1件: 299
1187Saline----10件: 6, 13, 17, 53, 67, 78, 86, 97, 168, 299
1188Saline 0.9% inhalation solution----1件: 299
1189Saline solution----4件: 2, 34, 288, 299
1190Salmeterol1件: Salmeterol2件: D00687 ,
D05792 		1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1191Saxagliptin1件: Saxagliptin1件: D08996 1件: DPP4 💬1件: Protein digestion and absorption 💬1件: 299
1192SB-656933 Tablets----2件: 97, 299
1193SB-656933-AAA----1件: 299
1194SB656933----1件: 299
1195SE10599----1件: 299
1196Seliciclib1件: Seliciclib---2件: 75, 299
1197Serum Zn----1件: 299
1198SF6----1件: 299
1199Short-acting Insulin (Actrapid)----1件: 299
1200Sildenafil1件: Sildenafil2件: D02229 ,
D08514 		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301
1201Sildenafil (Acute-1 hour)1件: Sildenafil2件: D02229 ,
D08514 		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299
1202Sildenafil (Subchronic-4 weeks)1件: Sildenafil2件: D02229 ,
D08514 		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299
1203Sildenafil 40mg oral capsule1件: Sildenafil2件: D02229 ,
D08514 		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299
1204Simvastatin1件: Simvastatin1件: D00434 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬21件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310
1205Simvastatin treatment for 28 days1件: Simvastatin1件: D00434 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 299
1206SIN ASIGNAR----1件: 299
1207Sitagliptin1件: Sitagliptin1件: D08516 1件: DPP4 💬1件: Protein digestion and absorption 💬4件: 6, 75, 233, 299
1208SLIT Amikacin1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
1209SLIT(TM) Amikacin1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
1210SmartPill Motility System & PillCam Patency Capsule----1件: 299
1211SMX----1件: 299
1212Snack beverage----1件: 299
1213SNSP113----1件: 299
1214Sodium (R)-8-methyl-2-(3-methylbenzofuran-2-yl)-5-(1-(tetrahydro-2H-pyran-4-yl)ethoxy)quinoline-4-ca----1件: 299
1215Sodium 4-Phenylbutyrate1件: Phenylbutyric acid---1件: 299
1216Sodium 4-Phenylbutyrate (4PBA)1件: Phenylbutyric acid---1件: 299
1217SODIUM ALGINATE1件: Alginic acid1件: D02324 --1件: 299
1218Sodium Bicarbonate1件: Sodium bicarbonate1件: D01203 --1件: 299
1219SODIUM BICARBONATE BP1件: Sodium bicarbonate1件: D01203 --1件: 299
1220Sodium chloride2件: Chloride ion,
Sodium chloride		1件: D02056 --21件: 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 168, 193, 227, 228, 271, 288, 299
1221Sodium chloride (7%)2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1222Sodium chloride 0,9%2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1223Sodium chloride 6%2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1224SODIUM CHLORIDE 7%2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1225SODIUM CHLORIDE PH. EUR.2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1226SODIUM CHLORIDE SOLUTION 0.9%2件: Chloride ion,
Sodium chloride		1件: D02056 --3件: 60, 288, 299
1227SODIUM NITRITE1件: Nitrite---2件: 86, 299
1228Sodium Pyruvate in 0.9% Sodium Chloride Solution2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1229Soluble fiber supplementation----1件: 299
1230Somalgen----1件: 299
1231Somatropin1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬19件: 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299
1232Sperti Del Sol Lamp----1件: 299
1233SPI-1005 Ebselen 200mg Capsule x11件: Ebselen---1件: 299
1234SPI-1005 Ebselen 200mg Capsule x21件: Ebselen---1件: 299
1235SPI-1005 Ebselen 200mg Capsule x31件: Ebselen---1件: 299
1236Spiriva1件: Tiotropium---1件: 299
1237Spiriva Respimat1件: Tiotropium---1件: 299
1238Spiriva Respimat 2.5 mcg1件: Tiotropium---1件: 299
1239Spiriva Respimat 2.5 microgram1件: Tiotropium---1件: 299
1240Spiriva Respimat 2.5 microgram, solution for inhalation1件: Tiotropium---1件: 299
1241Spirometry----1件: 299
1242Spirulina1件: Spirulina platensis---1件: 299
1243Spirulina platensis1件: Spirulina platensis---1件: 299
1244Sporanox1件: Itraconazole1件: D00350 --2件: 227, 299
1245Sporanox 10 mg/ml Oral Solution1件: Itraconazole1件: D00350 --1件: 299
1246Sputum----1件: 299
1247Sputum Collection----1件: 299
1248SPX-101----1件: 299
1249Ss-Adrenergic cocktail----1件: 299
1250Standard Care----2件: 81, 299
1251Standard Dose YPT-01----1件: 299
1252Standard Formula----1件: 299
1253Standard formula (Enfamil)----1件: 299
1254Standard Nutritional Supplement + PERT----1件: 299
1255Standard of care IV antibiotic(s)----1件: 299
1256Standard oxygen therapy/RA1件: Oxygen1件: D00003 --1件: 299
1257Standard sinus rinse----1件: 299
1258Standardized turmeric root extract1件: Turmeric---1件: 299
1259STERILE PYROGEN-FREE ISOTONIC NACL SOLUTE (0.9% W / V)----1件: 299
1260Study medication, azithromycin1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 299
1261SUB185183----1件: 299
1262Sulfamethoxazole1件: Sulfamethoxazole1件: D00447 --5件: 44, 49, 61, 85, 299
1263Sulfate1件: Sulfate ion---27件: 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299
1264Sulfato de amikacina1件: Amikacin2件: D00865 ,
D02543 		--1件: 299
1265Sulfur Colloid1件: Gelatin2件: D00115 ,
D06892 		--1件: 299
1266Sunflower oil1件: Sunflower oil1件: D09006 --3件: 46, 240, 299
1267Supplementation with vitamin D2/D31件: Ergocalciferol1件: D00187 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
1268Symbiotic Formula with DHA and antioxidants----1件: 299
1269Symdeko1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1270Symdeko/Trikafta2件: Ivacaftor,
Tezacaftor		2件: D09916 ,
D11041 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1271Symkevi1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1272Symkevi 100mg/150mg Film-coated tablets1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1273Synrinse----1件: 299
1274T 100 PARI----1件: 299
1275T-326----1件: 299
1276T100----1件: 299
1277T100 PARI----1件: 299
1278Ta1----1件: 299
1279Tacrolimus1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
1280Tacrolimus and MMF1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1281Tacrolimus Capsules1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 222, 299
1282Tacrolimus prolonged-release hard capsules2件: Manganese citrate,
Tacrolimus		2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1283Tad----1件: 299
1284TAD 600----1件: 299
1285Tadim----1件: 299
1286TAFLUPROST1件: Tafluprost1件: D06274 1件: PTGFR 💬3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬1件: 299
1287Talniflumate1件: Talniflumate1件: D02701 --1件: 299
1288TAUROURSODEOXYCHOLIC ACID1件: Tauroursodeoxycholic acid1件: D11836 --4件: 2, 13, 93, 299
1289TAZOBACTAM1件: Tazobactam1件: D00660 --1件: 299
1290TAZOBACTAM SODIUM1件: Tazobactam1件: D00660 --1件: 299
1291TBD----4件: 19, 86, 276, 299
1292TBM100----1件: 299
1293TBM100C----1件: 299
1294Technetium Sulfur Colloid1件: Gelatin2件: D00115 ,
D06892 		--1件: 299
1295Tedizolid1件: Tedizolid1件: D09685 --1件: 299
1296Tedizolid IV1件: Tedizolid1件: D09685 --1件: 299
1297Tedizolid PO1件: Tedizolid1件: D09685 --1件: 299
1298Tefibazumab1件: Tefibazumab1件: D06054 --1件: 299
1299Teicoplanin1件: Teicoplanin1件: D02142 --2件: 70, 299
1300Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution.1件: Teicoplanin1件: D02142 --1件: 299
1301Telavancin1件: Telavancin---1件: 299
1302Telavancin Injection1件: Telavancin---1件: 299
1303TERLIPRESSIN1件: Terlipressin1件: D06672 3件: AVPR1A,
AVPR1B,
AVPR2 💬		5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 299
1304Terlipressin acetate2件: Acetate,
Terlipressin		1件: D06672 3件: AVPR1A,
AVPR1B,
AVPR2 💬		5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 299
1305TEZ----1件: 299
1306TEZ/IVA----1件: 299
1307TEZACAFTOR1件: Tezacaftor1件: D11041 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1308Tezacaftor (TEZ)1件: Tezacaftor1件: D11041 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1309Tezacaftor/Ivacaftor2件: Ivacaftor,
Tezacaftor		2件: D09916 ,
D11041 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1310Tezacaftor/Ivacaftor + Ivacaftor2件: Ivacaftor,
Tezacaftor		2件: D09916 ,
D11041 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1311Tezacaftor/Ivacaftor 100mg/150mg2件: Ivacaftor,
Tezacaftor		2件: D09916 ,
D11041 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1312Tezacaftor/Ivacaftor/100mg/150mg2件: Ivacaftor,
Tezacaftor		2件: D09916 ,
D11041 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1313THA----3件: 46, 271, 299
1314Tham1件: Tromethamine1件: D00396 --1件: 299
1315The gut mycobiota and microbiota profile----1件: 299
1316The lung mycobiota and microbiota profile----1件: 299
1317Theophylline1件: Theophylline5件: D00371 ,
D01712 ,
D02017 ,
D06103 ,
D06104 		19件: ADORA1,
ADORA2A,
ADORA2B,
PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬		24件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 236, 299
1318Thymosin alpha 1----1件: 299
1319Ticarcillin1件: Ticarcillin1件: D08593 --1件: 299
1320Tigerase®----1件: 299
1321Tiotropium1件: Tiotropium---3件: 55, 85, 299
1322Tiotropium bromide1件: Tiotropium---1件: 299
1323Tiotropium Bromide (monohydrate)1件: Tiotropium---1件: 299
1324Tiotropium bromide 5 mcg1件: Tiotropium---1件: 299
1325Tiotropium bromide high1件: Tiotropium---1件: 299
1326Tiotropium bromide low1件: Tiotropium---1件: 299
1327Tiotropium bromide medium1件: Tiotropium---1件: 299
1328TIOTROPIUM BROMIDE MONOHYDRATE1件: Tiotropium---1件: 299
1329Tiotropium bromide-low dose-2.5mcg1件: Tiotropium---1件: 299
1330Tiotropium Respimat1件: Tiotropium---1件: 299
1331Tiotropium Respimat 1.25 microgram solution for inhalation1件: Tiotropium---1件: 299
1332Tiotropium Respimat 1.25 microgram, solution for inhalation1件: Tiotropium---1件: 299
1333Tiotropium Respimat 1.25 micrograms solution for inhalation1件: Tiotropium---1件: 299
1334Tiotropium Respimat® inhaler1件: Tiotropium---1件: 299
1335TIP----1件: 299
1336TIP (Tobramycin inhalation powder)1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1337TIS (Tobramycin Inhalation Solution)1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1338TIS or TIP----1件: 299
1339TMP1件: TMP---1件: 299
1340TNSE----1件: 299
1341Tobacco1件: Tobacco leaf---1件: 299
1342TOBI----1件: 299
1343TOBI (tobramycin)1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1344TOBI 300 mg / 5 mL nebuliser solution1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1345TOBI 300 mg/5 ml Lösung für einen1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1346TOBI 300 mg/5 ml Lösung für einen Vernebler1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1347TOBI 300 mg/5 ml Nebuliser Solution1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1348TOBI 300 mg/5 ml solución para inhalación por nebulizador1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1349TOBI 300 mg/5 ml, solution pour inhalation par nébuliseur1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1350TOBI 300mg/ 5ml solución para inhalación con nebulizador1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1351TOBI 300mg/5mL Nebuliser Solution1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1352Tobi 300mg/5ml Nebuliser solution.1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1353Tobi 300mg/5ml Solución para inhalación por nebulizador.1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1354Tobi Inhalant Product1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1355Tobi Nebcinal----1件: 299
1356TOBI PODHALER----1件: 299
1357TOBI PODHALER - 28 MG POLVERE PER INALAZIONE CAPSULA RIGIDA USO INALATORIO BLISTER(ALU/ALU) 56 CAPSULE + 1 INALATORE1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1358TOBI Podhaler 28 mg Hartkapseln mit Pulver zur Inhalation1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1359TOBI Podhaler 28 mg inhalációs por, kemény kapszula1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1360TOBI PODHALER*448CPS 28MG+10IN1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1361TOBI*NEBUL 56F 1D 300MG/5ML1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1362TOBI®1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1363TOBI™ Podhaler™ 112 mg inhaled twice daily----1件: 299
1364Tobramcyin----1件: 299
1365TOBRAMICINA1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1366Tobramicina polvere inalatoria1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1367TOBRAMICINA SOLFATO1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1368Tobramicyn----1件: 299
1369TOBRAMYCIN1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1370Tobramycin (Gernebcin®)1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1371Tobramycin / Bramitob1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1372Tobramycin / TOBI1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1373Tobramycin 100 PARI1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1374Tobramycin dry powder1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1375Tobramycin for Inhalation1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1376Tobramycin Inhalation Powder1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1377Tobramycin Inhalation Powder (TIP)1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1378Tobramycin Inhalation Powder TIP delivered by the T-326 Inhaler1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1379Tobramycin inhalation solution1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1380Tobramycin Inhalation Solution (TIS)1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1381Tobramycin inhalation solution using a PARI LC® Plus nebulizer.1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1382Tobramycin injection 40mg/1ml1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1383Tobramycin nebulized nasally1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1384Tobramycin Powder1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1385Tobramycin Solution for Inhalation1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1386Tobramycin solution for inhalation (TOBI)1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1387Tobramycin solution for inhalation 300 mg1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1388Tobramycin Steri-Neb 300 mg/5 ml, inhalation solution1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1389TOBRAMYCIN SULFATE2件: Sulfate ion,
Tobramycin		2件: D00063 ,
D02542 		--1件: 299
1390Tobramycine1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1391Tobramycinum1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1392Tobrineb/Bramitob----1件: 299
1393Tocotrienol1件: Tocotrienol---3件: 21, 156, 299
1394TOTTIZIM - 1 G/10 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO ENDOVENOSO 1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 10 ML----1件: 299
1395Tozinameran1件: Pfizer-BioNTech COVID-19 Vaccine1件: D11971 --1件: 299
1396TR02----1件: 299
1397Tranexamic acid1件: Tranexamic acid1件: D01136 1件: PLG 💬4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬6件: 46, 70, 215, 227, 288, 299
1398Treatment----2件: 41, 299
1399Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Ivacaftor, Elexacaftor-Tezacaftor-Ivacaftor4件: Elexacaftor,
Ivacaftor,
Lumacaftor,
Tezacaftor		4件: D09916 ,
D10134 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1400Treatment with polyethylene glycol (Macrogol 4000)1件: Polyethylene glycol1件: D03370 --1件: 299
1401Trifakta----1件: 299
1402Trikafta1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1403Trimethoprim1件: Trimethoprim2件: D00145 ,
D06236 		--7件: 36, 44, 49, 60, 61, 85, 299
1404Trimethoprim and Sulfamethoxazole2件: Sulfamethoxazole,
Trimethoprim		3件: D00145 ,
D00447 ,
D06236 		--1件: 299
1405Trimethoprim Sulfamethoxazole (TMP/SMX)3件: Sulfamethoxazole,
TMP,
Trimethoprim		3件: D00145 ,
D00447 ,
D06236 		--1件: 299
1406Trimethoprim-Sulfamethoxazole2件: Sulfamethoxazole,
Trimethoprim		3件: D00145 ,
D00447 ,
D06236 		--3件: 49, 61, 299
1407Trimethoprim/Sulfamethoxazole2件: Sulfamethoxazole,
Trimethoprim		3件: D00145 ,
D00447 ,
D06236 		--1件: 299
1408Trimethoprim/Sulfamethoxazole (TMP/SMX)3件: Sulfamethoxazole,
TMP,
Trimethoprim		3件: D00145 ,
D00447 ,
D06236 		--1件: 299
1409Trimetoprim----1件: 299
1410Triple combination therapy----1件: 299
1411Turmeric1件: Turmeric---4件: 140, 144, 158, 299
1412Ultrase----1件: 299
1413Ultrase® MT12----1件: 299
1414Ultrase® MT20----1件: 299
1415ULTRESA----1件: 299
1416Unconjugated Isoflavones 100 (PTI G-4660, 87% Genistein)1件: Genistein1件: D11680 --1件: 299
1417Uridine1件: Uridine---1件: 299
1418Urinary collect----1件: 299
1419Urinary levels of PIIINP as a marker of changes in renal function----1件: 299
1420Ursodiol1件: Ursodeoxycholic acid1件: D00734 1件: NR1H4 💬1件: Bile secretion 💬6件: 8, 20, 93, 97, 234, 299
1421V-Fend----1件: 299
1422Vaccin grippal pandémique H1N1----1件: 299
1423Vaccination with vaccine against hepatitis A and B----1件: 299
1424Valganciclovir1件: Valganciclovir1件: D02495 --6件: 28, 60, 85, 97, 299, 331
1425Valganciclovir [Valcyte]1件: Valganciclovir1件: D02495 --1件: 299
1426Vancomycin1件: Vancomycin2件: D00212 ,
D00926 		--7件: 46, 70, 94, 96, 97, 296, 299
1427Vancomycin hydrochloride inhalation powder1件: Vancomycin2件: D00212 ,
D00926 		--1件: 299
1428Vancomycin inhalation powder1件: Vancomycin2件: D00212 ,
D00926 		--1件: 299
1429Vantobra (tobramycin)1件: Tobramycin2件: D00063 ,
D02542 		--1件: 299
1430Vardenafil1件: Vardenafil3件: D02731 ,
D03260 ,
D08668 		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬3件: 13, 86, 299
1431Vaxzevria1件: AstraZeneca COVID-19 Vaccine---1件: 299
1432Vaxzevria suspension for injection COVID-19 Vaccine (ChAdOx1-S1件: AstraZeneca COVID-19 Vaccine---1件: 299
1433VEDROP1件: Tocofersolan1件: D06174 --1件: 299
1434Ventolin1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1435Ventolin® Evohaler1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1436Ventolin¿ Evohaler¿1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
1437Vfend1件: Voriconazole1件: D00578 --1件: 299
1438VFEND 40 mg/ml powder for oral suspension1件: Voriconazole1件: D00578 --1件: 299
1439Vitamin B121件: Cyanocobalamin4件: D00166 ,
D03615 ,
D03616 ,
D03617 		--4件: 6, 201, 229, 299
1440Vitamin D1件: Vitamin D---24件: 3, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299
1441Vitamin D Oil1件: Vitamin D---1件: 299
1442Vitamin D Powder1件: Vitamin D---1件: 299
1443Vitamin D21件: Ergocalciferol1件: D00187 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬3件: 49, 84, 299
1444Vitamin D31件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬12件: 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299
1445Vitamin E1件: Vitamin E1件: D02331 --11件: 2, 6, 13, 20, 46, 90, 96, 97, 206, 299, 317
1446VITAMIN E - TGPS1件: Vitamin E1件: D02331 --1件: 299
1447Vitamin K1件: Phylloquinone1件: D00148 --5件: 13, 46, 96, 97, 299
1448Vitamin K supplementation, dose #11件: Phylloquinone1件: D00148 --1件: 299
1449Vitamin K supplementation, dose #21件: Phylloquinone1件: D00148 --1件: 299
1450Vitamin: Choline Bitartrate (2-hydroxyethyl) trimethylammonium salt 1:11件: Choline1件: D07690 --1件: 299
1451Voriconazole1件: Voriconazole1件: D00578 --2件: 60, 299
1452VR496----1件: 299
1453VRT-813077----1件: 299
1454VRT-826809----1件: 299
1455VRT-893661----1件: 299
1456VRT-893661 VRT-0893661----1件: 299
1457VX-121----1件: 299
1458VX-121/TEZ/D-IVA----1件: 299
1459VX-121/tezacaftor/deutivacaftor2件: Deutivacaftor,
Tezacaftor		2件: D11041 ,
D11423 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1460VX-152----1件: 299
1461VX-371----1件: 299
1462VX-371 in hypertonic saline----1件: 299
1463VX-371 in saline----1件: 299
1464VX-440----1件: 299
1465VX-445----1件: 299
1466VX-445 / TEZ / IVA----1件: 299
1467VX-445 / TEZ / IVA FDC----1件: 299
1468VX-445 /TEZ/IVA----1件: 299
1469VX-445/TEZ/IVA----1件: 299
1470VX-561----1件: 299
1471VX-561 (CTP-656)----1件: 299
1472VX-6591件: VX-659---1件: 299
1473VX-659/ TEZ/IVA1件: VX-659---1件: 299
1474VX-659/TEZ/IVA1件: VX-659---1件: 299
1475VX-659/Tezacaftor/Ivacaftor3件: Ivacaftor,
Tezacaftor,
VX-659		2件: D09916 ,
D11041 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1476VX-661----1件: 299
1477VX-661 / VX-770----1件: 299
1478VX-661 Plus Ivacaftor Combination1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1479VX-661, VRT-893661----1件: 299
1480VX-661/Ivacaftor1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1481VX-661/ivacaftor (VX-770) 100mg/150 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1482VX-661/ivacaftor 100 mg/ 150 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1483VX-661/ivacaftor 100mg/150 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1484VX-661/ivacaftor 100mg/150mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1485VX-661/ivacaftor 50 mg/ 75 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
1486VX-661/VX-770----1件: 299
1487VX-661/VX-770 (TEZ/IVA)----1件: 299
1488VX-77----1件: 299
1489VX-770----1件: 299
1490VX-770, VRT-8130077----1件: 299
1491VX-770, VRT-813077----1件: 299
1492VX-809----1件: 299
1493VX-809 & VX-770----1件: 299
1494VX-809 / VX-770----1件: 299
1495VX-809, VRT-826809----1件: 299
1496VX-809/VX-770----1件: 299
1497Water1件: Water1件: D00001 --23件: 2, 5, 6, 13, 17, 19, 22, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299
1498Water for injections1件: Water1件: D00001 --1件: 299
1499WATER FOR INJECTIONS, EP1件: Water1件: D00001 --1件: 299
1500Whole body Protein turnover----4件: 19, 46, 96, 299
1501Whole body Protein Turnover Study----1件: 299
1502Xenon1件: Xenon2件: D01901 ,
D06339 		--4件: 22, 85, 228, 299
1503Xenon-1291件: Xenon2件: D01901 ,
D06339 		--1件: 299
1504Xolair1件: Omalizumab1件: D05251 1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬2件: 46, 299
1505Xolair 150 mg Pulver und Injektionslösung zur Herstellung einer Injektionslösung1件: Omalizumab1件: D05251 1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299
1506Xylitol1件: Xylitol1件: D00061 --2件: 53, 299
1507Zadaxin----2件: 65, 299
1508ZAVESCA1件: Miglustat1件: D05032 1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 19, 256, 299
1509Zenpep----2件: 298, 299
1510Zinc1件: Zinc---3件: 2, 171, 299
1511Zinc acetate2件: Acetate,
Zinc acetate		1件: D06408 --2件: 171, 299
1512Zinc acetate (20mg/d)3件: Acetate,
Zinc,
Zinc acetate		1件: D06408 --1件: 299
1513ZITHOMAX 40 mg/ml ENFANTS----1件: 299
1514Zithromax1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--2件: 228, 299
1515ZITHROMAX 250 mg1件: Azithromycin3件: D02134 ,
D06390 ,
D07486 		--1件: 299
1516Zitromax----2件: 228, 299
1517Zn----2件: 113, 299
1518Zoledronic acid1件: Zoledronic acid4件: D01968 ,
D06378 ,
D06379 ,
D08689 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬12件: 5, 6, 13, 17, 46, 93, 95, 96, 270, 274, 299, 333